{
  "version": "1.0",
  "options": [
    {
      "n": "H01A",
      "v": "Acute and Chronic Sinusitis"
    },
    {
      "n": "H01A_1",
      "v": "Sinus Disease: No x-ray",
      "t": "1. In adults with sinus disease, we recommend against <b>XR</b>. (↓↓)",
      "c": "H01A"
    },
    {
      "n": "H01A_2",
      "v": "Acute Sinusitis, uncomplicated",
      "t": "2. In adults with uncomplicated acute sinusitis (≤4 weeks), we recommend against imaging. (↓↓)",
      "c": "H01A"
    },
    {
      "n": "H01A_3",
      "v": "Acute Sinusitis with suspected complications: initial imaging",
      "t": "3. In adults with acute sinusitis with suspected complications, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "H01A"
    },
    {
      "n": "H01A_3_1",
      "v": "Sinusitis with Intraorbital/Intracranial Complications: further investigation (MRI)",
      "t": "↪ 3.1 In adults where there is clinical or radiologic concern for intraorbital or intracranial complication, we suggest <b>MRI</b> as the next imaging modality.",
      "c": "H01A"
    },
    {
      "n": "H01A_4",
      "v": "Chronic or Recurrent Acute Sinusitis: initial imaging",
      "t": "4. In adults who meet the definition (e.g., Canadian Consensus Guidelines) of chronic sinusitis OR for recurrent acute sinusitis, we suggest <b>CT</b> as the initial imaging modality (↑).",
      "c": "H01A"
    },
    {
      "n": "H01B",
      "v": "Sinonasal Tumours"
    },
    {
      "n": "H01B_1",
      "v": "Suspected Sinonasal Tumour: initial imaging",
      "t": "1. In adults with suspected sinonasal tumour, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "H01B"
    },
    {
      "n": "H01B_2",
      "v": "Sinonasal Tumour Follow-up: further investigation (MRI)",
      "t": "↪ 1.1 In adults with suspected sinonasal tumour on <b>CT</b>, we recommend<b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "H01B"
    },
    {
      "n": "H02",
      "v": "Tinnitus",
      "t": "See 'Pulsatile Tinnitus' vs 'Non-pulsatile tinnitus'"
    },
    {
      "n": "H02A",
      "v": "Pulsatile Tinnitus",
      "c": "H02"
    },
    {
      "n": "H02A_1",
      "v": "Pulsatile Tinnitus: initial imaging",
      "t": "1. In adults with pulsatile tinnitus, we suggest <b>CT</b>/<b>CT</b>A or <b>MRI</b>/<b>MRA</b> as the initial imaging modality.",
      "c": "H02A"
    },
    {
      "n": "H02B",
      "v": "Non-pulsatile Tinnitus",
      "c": "H02"
    },
    {
      "n": "H02B_1",
      "v": "Symmetrical Non-pulsatile Tinnitus",
      "t": "1. In adults with symmetrical atraumatic non-pulsatile tinnitus with no associated neurological signs and symptoms, we recommend against imaging. (↓↓)",
      "c": "H02B"
    },
    {
      "n": "H02B_2",
      "v": "Asymmetric Non-pulsatile Tinnitus",
      "t": "2. In adults with associated neurological signs and symptoms꙳ OR with asymmetric atraumatic non-pulsatile tinnitus, we recommend <b>MRI</b> of <b>internal auditory canals</b> as the initial imaging modality. (↑↑)",
      "c": "H02B"
    },
    {
      "n": "H02B_2_1",
      "v": "Internal Auditory Canal Assessment: <b>MRI</b> unavailable/contraindicated",
      "t": "↪ 2.1 If <b>MRI</b> internal auditory canals is unavailable or contraindicated, we recommend <b>CT</b>. (↑↑)",
      "c": "H02B"
    },
    {
      "n": "H03",
      "v": "Thyroid and Parathyroid Disease"
    },
    {
      "n": "H03A",
      "v": "Palpable Nodule and Goiter",
      "t": "Palpable nodule, including goiter",
      "c": "H03"
    },
    {
      "n": "H03A_1",
      "v": "Thyroid Nodule/Goiter: initial imaging",
      "t": "1. In adults with palpable thyroid nodule or goiter, we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "H03A"
    },
    {
      "n": "H03A_1_1",
      "v": "Thyroid nodule/goiter with suspicion for invasive thyroid cancer: further investigation",
      "t": "↪ 1.1 If further investigation is required to evaluate for indications such as suspicion of invasive thyroid cancer, substernal and deep extension, tracheal compression, we recommend <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "H03A"
    },
    {
      "n": "H03B",
      "v": "Thyrotoxicosis and Hyperthyroidism",
      "c": "H03"
    },
    {
      "n": "H03B_1",
      "v": "Thyrotoxicosis/Hyperthyroidism: initial imaging",
      "t": "1. In adults with biochemical confirmation of thyrotoxicosis or hyperthyroidism (i.e., supressed TSH), we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "H03B"
    },
    {
      "n": "H03B_1_1",
      "v": "Thyroid Focal Abnormality",
      "t": "↪ 1.1 If focal abnormality is detected on <b>US</b>, we suggest <b>NM</b>. (↑)",
      "c": "H03B"
    },
    {
      "n": "H03C",
      "v": "Primary Hyperparathyroidism",
      "c": "H03"
    },
    {
      "n": "H03C_1",
      "v": "Primary Hyperparathyroidism: initial imaging",
      "t": "1. In adults with biochemically proven primary hyperparathyroidism, we recommend <b>US and <b>NM</b> as the initial imaging modalities for operative consideration. (↑↑)",
      "c": "H03C"
    },
    {
      "n": "H03C_1_1",
      "v": "Primary Hyperparathyroidism: further investigation",
      "t": "↪ 1.1 If <b>US</b> and <b>NM</b> are nondiagnostic or discordant, we suggest <b>CT</b> as the next imaging modality at the physicians’ discretion. (↑)",
      "c": "H03C"
    },
    {
      "n": "H04",
      "v": "Neck mass of unknown origin, including salivary gland mass"
    },
    {
      "n": "H04_1",
      "v": "Suspicious Neck Mass: initial imaging",
      "t": "1. In adults with neck mass of unknown origin with clinical concern for malignancy, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "H04"
    },
    {
      "n": "H04_2",
      "v": "Non-suspicious Neck Mass: initial imaging",
      "t": "2. In adults with neck mass of unknown origin with low clinical concern for malignancy, we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "H04"
    },
    {
      "n": "H04_2_1",
      "v": "Neck Mass Characterization: further investigation",
      "t": "↪ 2.1 If further investigation is required to characterize the mass, we recommend <b>CT</b> or <b>MRI</b> as the next imaging modality based on <b>US</b> findings. (↑↑)",
      "c": "H04"
    },
    {
      "n": "H05",
      "v": "Acute Sialadenitis"
    },
    {
      "n": "H05_1",
      "v": "Acute Sialadenitis: initial imaging",
      "t": "1. In adults with suspected acute sialadenitis with or without stone, we recommend <b>CT</b> as the initial imaging modality. (EPc)",
      "c": "H05"
    },
    {
      "n": "H05_1_1",
      "v": "Sialadenitis Alternative: alternative imaging",
      "t": "↪ 1.1 If <b>CT</b> is unavailable, we recommend <b>US</b> as the initial imaging modality. (EPc)",
      "c": "H05"
    },
    {
      "n": "H06",
      "v": "Chronic Salivary Conditions"
    },
    {
      "n": "H06_1",
      "v": "Chronic Salivary Disease: initial imaging",
      "t": "1. In adults with xerostomia, suspected chronic sialadenitis, or suspected autoimmune/connective tissue disease, we recommend <b>US</b> or <b>CT</b> as the initial imaging modality. (↑↑ or EPc)",
      "c": "H06"
    },
    {
      "n": "H06_1_1",
      "v": "Salivary Disease Follow-up: further investigation",
      "t": "↪ 1.1  If further investigation is required, we suggest <b>MRI</b>/<b>MR</b> sialography as the next imaging modality. (↑)",
      "c": "H06"
    },
    {
      "n": "H07",
      "v": "Temporomandibular Joint Dysfunction"
    },
    {
      "n": "H07_1",
      "v": "TMJ Dysfunction",
      "t": "1. In adults with temporomandibular joint dysfunction, we suggest against imaging, unless surgery is being considered. (↓)",
      "c": "H07"
    },
    {
      "n": "H07_1_1",
      "v": "TMJ dysfunction/TMD after conservative management failure",
      "t": "↪ 1.1 In adults with clinically significant mechanical symptoms suggestive of temporomandibular joint dysfunction where surgery is being considered after failure of conservative management, we recommend <b>MRI</b>. (↑↑)",
      "c": "H07"
    },
    {
      "n": "M1",
      "v": "Osteomyelitis Including Diabetic Foot",
      "t": "Osteomyelitis, including diabetic foot"
    },
    {
      "n": "M1_1",
      "v": "Suspected Osteomyelitis / diabetic foot: initial imaging",
      "t": "1. In adults with suspected osteomyelitis, including the diabetic foot, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M1"
    },
    {
      "n": "M1_1_1",
      "v": "Osteomyelitis: further investigation",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M1"
    },
    {
      "n": "M1_1_2",
      "v": "Osteomyelitis: alternative imaging",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast) or <b>NM</b> (bone scan). For bone scan, the radioisotope and protocol employed may vary based on clinical presentation, regional practice preferences and resource availability. (↑)",
      "c": "M1"
    },
    {
      "n": "M1_2",
      "v": "Osteomyelitis sequestra evaluation / biopsy guidance",
      "t": "2. In adults with suspected osteomyelitis, we recommend <b>CT</b> for evaluation of sequestra or for guiding biopsy. (↑↑)",
      "c": "M1"
    },
    {
      "n": "M1_3",
      "v": "Osteomyelitis,﹘superficial collection evaluation",
      "t": "3. In adults with suspected osteomyelitis, where <b>MRI</b> or <b>CT</b> were not performed, we suggest <b>US</b> to evaluate for superficial fluid collections. (↑)",
      "c": "M1"
    },
    {
      "n": "M2",
      "v": "Septic Arthritis"
    },
    {
      "n": "M2_1",
      "v": "Septic Arthritis: initial imaging",
      "t": "1. In adults with suspected septic arthritis, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M2"
    },
    {
      "n": "M2_1_1",
      "v": "Septic Arthritis: further investigation",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M2"
    },
    {
      "n": "M2_1_2",
      "v": "Septic Arthritis: alternative imaging",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M2"
    },
    {
      "n": "M2_2",
      "v": "Septic arthritis﹘joint effusion and juxta-articular fluid collections: evaluation",
      "t": "2. In adults with suspected septic arthritis, where <b>MRI</b> or <b>CT</b> were not performed, we suggest <b>US</b> to evaluate for effusion or juxta-articular fluid collections. (↑)",
      "c": "M2"
    },
    {
      "n": "M2_3",
      "v": "Arthrocentesis Guidance",
      "t": "3. In adults with suspected septic arthritis, we suggest <b>US</b> or Fluoroscopy to facilitate arthrocentesis, immediately after <b>XR</b>, if bedside arthrocentesis is not feasible. (EPc)",
      "c": "M2"
    },
    {
      "n": "M3",
      "v": "Soft Tissue Infection"
    },
    {
      "n": "M3_1",
      "v": "Soft Tissue Infection: initial imaging",
      "t": "1. In adults with suspected soft tissue infection, including necrotizing fasciitis, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M3"
    },
    {
      "n": "M3_2",
      "v": "Deep Soft Tissue Infection: further investigation",
      "t": "2. In adults with suspected deep or aggressive soft tissue infection, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M3"
    },
    {
      "n": "M3_2_1",
      "v": "Deep Soft Tissue Infection: alternative imaging",
      "t": "↪ 2.1 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M3"
    },
    {
      "n": "M3_3",
      "v": "Soft Tissue Infection﹘superficial collections: evaluation",
      "t": "3. In adults with suspected soft tissue infection, we suggest <b>US</b> to evaluate for superficial fluid collections. (↑)",
      "c": "M3"
    },
    {
      "n": "M3_3_1",
      "v": "Complex Soft Tissue Infection",
      "t": "↪ 3.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M3"
    },
    {
      "n": "M3_3_2",
      "v": "Alternative Complex Infection Imaging",
      "t": "↪ 3.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M3"
    },
    {
      "n": "M4",
      "v": "Primary Bone Tumour",
      "t": "Bone tumour — Primary"
    },
    {
      "n": "M4_1",
      "v": "Suspected Primary Bone Tumour: initial imaging",
      "t": "1. In adults with suspected primary bone tumour, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M4"
    },
    {
      "n": "M4_1_1",
      "v": "Bone Tumour Further Investigation",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M4"
    },
    {
      "n": "M4_1_2",
      "v": "Alternative Bone Tumour Imaging",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M4"
    },
    {
      "n": "M4_1_3",
      "v": "Equivocal Bone Tumour",
      "t": "↪ 1.3 If <b>XR</b>, <b>MRI</b> or <b>CT</b> remain equivocal, we suggest <b>NM</b> (bone scan). (EPc)",
      "c": "M4"
    },
    {
      "n": "M5",
      "v": "Bone Metastases",
      "t": "Bone tumour — Metastases"
    },
    {
      "n": "M5_1",
      "v": "Known Primary Cancer",
      "t": "1. In adults with known primary cancer (non-myeloma), we recommend <b>NM</b> (bone scan) as the initial imaging modality to assess for skeletal metastases. (↑↑)",
      "c": "M5"
    },
    {
      "n": "M5_2",
      "v": "Focal Symptomatic Sites",
      "t": "2. In adults with suspected bone metastases, we recommend <b>XR</b> as the initial imaging modality for assessment of focal symptomatic sites, or for correlation with a <b>NM</b>, <b>MRI</b> or <b>CT</b> finding. (↑↑)",
      "c": "M5"
    },
    {
      "n": "M5_3",
      "v": "Local Metastasis Assessment",
      "t": "3. In adults with metastases seen on <b>XR</b> requiring further local assessment or staging, we recommend <b>MRI</b>. (↑↑)",
      "c": "M5"
    },
    {
      "n": "M5_3_1",
      "v": "Alternative Metastasis Assessment",
      "t": "↪ 3.1 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M5"
    },
    {
      "n": "M5_4",
      "v": "Skeletal Survey",
      "t": "4. In adults with suspected metastases, we recommend against skeletal survey <b>XR</b>. (↓↓)",
      "c": "M5"
    },
    {
      "n": "M5_5",
      "v": "Advanced Metastasis Imaging Techniques",
      "t": "5. In adults with suspected bone metastases, whole-body <b>CT</b>, whole-body <b>MRI</b>, and <b>PET</b> are evolving techniques and may be used depending on regional practice preferences and resource availability. (EPc)",
      "c": "M5"
    },
    {
      "n": "M6",
      "v": "Myeloma",
      "t": "Bone tumour — Myeloma"
    },
    {
      "n": "M6_1",
      "v": "Myeloma staging: initial imaging",
      "t": "1. In adults with suspected myeloma, we recommend whole-body <b>CT</b> (low dose) or <b>PET</b>/<b>CT</b> as the initial imaging modality for staging. (↑↑)",
      "c": "M6"
    },
    {
      "n": "M6_1_1",
      "v": "Myeloma staging: further investigation",
      "t": "↪ 1.1 If whole-body <b>CT</b> or <b>PET</b>/<b>CT</b> is negative or unavailable, we recommend whole-body <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M6"
    },
    {
      "n": "M6_1_2",
      "v": "Myeloma staging: alternative imaging",
      "t": "↪ 1.2 If whole-body <b>CT</b>, <b>PET</b>/<b>CT</b>, and <b>MRI</b> are unavailable or contraindicated, we suggest <b>XR</b> (skeletal survey). (↑)",
      "c": "M6"
    },
    {
      "n": "M6_2",
      "v": "Known Myeloma﹘focal symptomatic sites: assessment",
      "t": "2. In adults with known myeloma, we recommend <b>XR</b> for assessment of focal symptomatic sites, or for correlation with an <b>MRI</b> or <b>CT</b> finding. (↑↑)",
      "c": "M6"
    },
    {
      "n": "M6_3",
      "v": "Myeloma﹘bone scan / <b>NM</b>: not recommended",
      "t": "3. In adults with suspected myeloma, we recommend against <b>NM</b> (bone scan). (↓↓)",
      "c": "M6"
    },
    {
      "n": "M7",
      "v": "Soft Tissue Mass or Tumour"
    },
    {
      "n": "M7_1",
      "v": "Superficial Soft Tissue Mass or Tumour: initial imaging",
      "t": "1. In adults with superficial soft tissue mass, we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "M7"
    },
    {
      "n": "M7_1_1",
      "v": "Superficial Mass or Tumour: further investigation",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M7"
    },
    {
      "n": "M7_2",
      "v": "Deep Soft Tissue Mass or Tumour: initial imaging",
      "t": "2. In adults with deep or large soft tissue mass (≥5 cm), we recommend <b>MRI</b> as the initial imaging modality. (↑↑)",
      "c": "M7"
    },
    {
      "n": "M7_2_1",
      "v": "Deep Soft Tissue Mass or Tumour: alternative imaging",
      "t": "↪ 2.1 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M7"
    },
    {
      "n": "M7_3",
      "v": "Superficial Soft Tissue Mass or Tumour: Bone Involvement Assessment",
      "t": "3. In adults with soft tissue masses, we recommend <b>XR</b> for evaluation of calcification, or if bone/joint involvement is suspected, after <b>US</b>. (↑↑)",
      "c": "M7"
    },
    {
      "n": "M8",
      "v": "Non-periarticular Soft Tissue Pain",
      "t": "Soft tissue pain (non-periarticular)"
    },
    {
      "n": "M8_1",
      "v": "Soft Tissue Pain: initial imaging",
      "t": "1. In adults with non-joint soft tissue pain, we recommend <b>US</b> as the initial imaging modality. (EPc)",
      "c": "M8"
    },
    {
      "n": "M8_1_1",
      "v": "Complex Soft Tissue Pain",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (EPc)",
      "c": "M8"
    },
    {
      "n": "M8_1_2",
      "v": "Alternative Pain Imaging",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> (with contrast). (EPc)",
      "c": "M8"
    },
    {
      "n": "M8_2",
      "v": "Regional Bone Assessment",
      "t": "2. In adults with non-joint soft tissue pain, we suggest <b>XR</b> for evaluation of regional bone pathology. (EPc)",
      "c": "M8"
    },
    {
      "n": "M9",
      "v": "Osteoarthritis/Crystalline Arthropathy/Gout/Pseudogout",
      "t": "Osteoarthritis/ Crystalline Arthropathy"
    },
    {
      "n": "M9_1",
      "v": "Suspected Arthritis",
      "t": "1. In adults with suspected osteoarthritis or crystalline arthropathy, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M9"
    },
    {
      "n": "M9_2",
      "v": "Gout Assessment",
      "t": "2. In adults with suspected gout, we suggest <b>US</b> as a complement to <b>XR</b> to identify tophi. (↑)",
      "c": "M9"
    },
    {
      "n": "M9_3",
      "v": "Advanced Gout Imaging",
      "t": "3. In adults with suspected gout, <b>CT</b> (dual-energy) may be used depending on regional practice preferences and resource availability. (EPc)",
      "c": "M9"
    },
    {
      "n": "M10",
      "v": "Inflammatory Arthropathy",
      "t": "Inflammatory Arthropathy (Rheumatoid/ Peripheral Spondyloarthropathy)"
    },
    {
      "n": "M10_1",
      "v": "Suspected Inflammatory Arthritis",
      "t": "1. In adults with suspected inflammatory arthropathy, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M10"
    },
    {
      "n": "M10_1_1",
      "v": "Synovitis Evaluation",
      "t": "↪ 1.1 If further investigation is required for evaluation of findings such as effusion, synovitis, erosions and enthesitis, we suggest <b>US</b> as the next imaging modality. (↑)",
      "c": "M10"
    },
    {
      "n": "M10_1_2",
      "v": "Multifocal Joint Assessment",
      "t": "↪ 1.2 In adults with multifocal joint pain, we suggest <b>NM</b> (bone scan) as an alternative to <b>US</b> to determine the distribution of synovitis. (↑)",
      "c": "M10"
    },
    {
      "n": "M10_1_3",
      "v": "Advanced Arthritis Assessment",
      "t": "↪ 1.3 If further investigation is required for evaluation of findings such as acute synovitis, cartilage damage, erosions, and bone marrow edema OR as an alternative to <b>US</b>, we suggest <b>MRI</b> as the next imaging modality. (↑)",
      "c": "M10"
    },
    {
      "n": "M11",
      "v": "Axial Spondyloarthropathy",
      "t": "Spondyloarthropathy (Axial)"
    },
    {
      "n": "M11_1",
      "v": "Initial Spondyloarthropathy Assessment",
      "t": "1. In adults with suspected axial spondyloarthropathy, we recommend <b>XR</b> of the sacroiliac joints ± spine as the initial imaging investigation. (↑↑)",
      "c": "M11"
    },
    {
      "n": "M11_1_1",
      "v": "Advanced Spondyloarthropathy",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> of the sacroiliac joints ± spine as the next imaging investigation. (↑↑)",
      "c": "M11"
    },
    {
      "n": "M11_1_2",
      "v": "Alternative Spondyloarthropathy: <b>CT</b>",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> of the sacroiliac joints ± spine. (↑)",
      "c": "M11"
    },
    {
      "n": "M11_2",
      "v": "Spondyloarthropathy Nuclear Medicine: Not Recommended",
      "t": "2. In adults with suspected axial spondyloarthropathy, we recommend against <b>NM</b> (bone scan). (↓↓)",
      "c": "M11"
    },
    {
      "n": "M12",
      "v": "Non-joint Bone Pain",
      "t": "Bone pain (non-joint)"
    },
    {
      "n": "M12_1",
      "v": "Non-traumatic Bone Pain: initial imaging",
      "t": "1. In adults with non-traumatic, non-joint bone pain, we recommend <b>XR</b> of the symptomatic area(s) as the initial imaging modality. (↑↑)",
      "c": "M12"
    },
    {
      "n": "M12_1_1",
      "v": "Complex Bone Pain: <b>MRI</b>",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M12"
    },
    {
      "n": "M12_1_2",
      "v": "Alternative Pain Assessment",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b>. (EPc)",
      "c": "M12"
    },
    {
      "n": "M12_1_3",
      "v": "Limited Access Pain Assessment",
      "t": "↪ 1.3 If <b>CT</b> is unavailable, we recommend <b>NM</b> (bone scan). (↑↑)",
      "c": "M12"
    },
    {
      "n": "M13",
      "v": "Metabolic Bone Disease, including osteoporosis and osteomalacia",
      "t": "Metabolic bone disease, including osteoporosis and osteomalacia"
    },
    {
      "n": "M13_1",
      "v": "Osteoporosis Assessment / Bone Mineral Density",
      "t": "1. In adults with suspected osteoporosis, we recommend Dual-energy X-ray absorptiometry (DEXA) for the measurement of bone mineral density. (↑↑)",
      "c": "M13"
    },
    {
      "n": "M13_2",
      "v": "Focal Metabolic Disease",
      "t": "2. In adults with suspected metabolic bone disease with pain or focal area of concern, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M13"
    },
    {
      "n": "M13_2_1",
      "v": "Complex Metabolic Disease",
      "t": "↪ 2.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M13"
    },
    {
      "n": "M13_2_2",
      "v": "Alternative Metabolic Assessment",
      "t": "↪ 2.2 If <b>MRI</b> is not available or is contraindicated, we suggest <b>CT</b> to evaluate focal pain. (↑)",
      "c": "M13"
    },
    {
      "n": "M13_3",
      "v": "Multifocal Disease",
      "t": "3. In adults with suspected metabolic bone disease with multi-focal areas of pain or concern, we suggest <b>NM</b> (bone scan) as the initial imaging modality. (↑)",
      "c": "M13"
    },
    {
      "n": "M14",
      "v": "Stress fracture (insufficiency, fatigue)",
      "t": "Stress fracture (insufficiency, fatigue)"
    },
    {
      "n": "M14_1",
      "v": "Stress fracture: initial imaging",
      "t": "1. In adults with suspected stress (fatigue or insufficiency) fracture, we recommend <b>XR</b> of the area of interest as the initial imaging modality. (↑↑)",
      "c": "M14"
    },
    {
      "n": "M14_1_1",
      "v": "Stress fracture: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required for evaluation of suspected stress fracture, we recommend <b>MRI</b> for the pelvis and hip and suggest <b>MRI</b> for any other sites as the next imaging modality. (↑↑/EPc)",
      "c": "M14"
    },
    {
      "n": "M14_1_2",
      "v": "Stress fracture: Alternative Assessment",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or is contraindicated or would result in a clinically significant delay in diagnosis, we suggest <b>CT</b>. (↑)",
      "c": "M14"
    },
    {
      "n": "M14_1_3",
      "v": "Stress fracture: <b>CT</b> Unavailable",
      "t": "↪ 1.3 If <b>CT</b> is unavailable, we suggest <b>NM</b> (bone scan). (↑)",
      "c": "M14"
    },
    {
      "n": "M15",
      "v": "Chest Wall Pain"
    },
    {
      "n": "M15_1",
      "v": "Non-traumatic Chest Wall: initial imaging",
      "t": "1. In adults with non-traumatic chest wall pain, we recommend <b>XR</b> of the chest ± ribs as the initial imaging investigation. (↑↑)",
      "c": "M15"
    },
    {
      "n": "M15_1_1",
      "v": "Focal Chest Wall: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required for evaluation of focal chest wall or joint area of concern, we suggest <b>US</b> as the next imaging modality. (↑)",
      "c": "M15"
    },
    {
      "n": "M15_1_2",
      "v": "Complex Chest Wall: Further Investigation",
      "t": "↪ 1.2 If further investigation is required, we recommend <b>MRI</b>. (↑↑)",
      "c": "M15"
    },
    {
      "n": "M15_1_3",
      "v": "Diffuse Chest Wall Pathology: follow-up imaging",
      "t": "↪ 1.3 If further investigation is required for evaluation of diffuse chest wall or intra-thoracic pathology, we recommend <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "M15"
    },
    {
      "n": "M16",
      "v": "Shoulder Pain or Instability"
    },
    {
      "n": "M16_1",
      "v": "Shoulder Assessment: initial imaging",
      "t": "1. In adults with shoulder pain or instability, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M16"
    },
    {
      "n": "M16_1_1",
      "v": "Shoulder Assessment: follow-up imaging / Rotator Cuff Assessment",
      "t": "↪ 1.1 If further investigation is required for evaluation of soft tissue pathology, such as rotator cuff tear, tendinopathy, effusion, bursitis, soft tissue calcification, or extra-articular impingement, we recommend <b>US</b> as the next imaging modality. (↑↑)",
      "c": "M16"
    },
    {
      "n": "M16_1_2",
      "v": "Shoulder Assessment: Further Investigation",
      "t": "↪ 1.2 If further investigation is required OR as an alternative to <b>US</b>, we recommend <b>MRI</b>. (↑↑)",
      "c": "M16"
    },
    {
      "n": "M17",
      "v": "Elbow pain"
    },
    {
      "n": "M17_1",
      "v": "Elbow joint pain: initial imaging",
      "t": "1. In adults with elbow joint pain of suspected articular origin, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M17"
    },
    {
      "n": "M17_1_1",
      "v": "Elbow joint pain: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M17"
    },
    {
      "n": "M17_2",
      "v": "Elbow tendon / nerve compression / effusion / synovitis / bursitis: initial imaging",
      "t": "2. In adults with elbow pain with suspected tendon pathology, nerve compression, effusion, synovitis, or bursitis, we recommend <b>XR</b> or <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "M17"
    },
    {
      "n": "M17_2_1",
      "v": "Elbow tendon / nerve compression / effusion / synovitis / bursitis: follow-up imaging",
      "t": "↪ 2.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M17"
    },
    {
      "n": "M17_3",
      "v": "Elbow bone pre-operative evaluation",
      "t": "3. In adults with elbow pain, after <b>XR</b>, we suggest <b>CT</b> for evaluation of clinically relevant bone anatomy, in the context of pre-operative planning. (↑)",
      "c": "M17"
    },
    {
      "n": "M18",
      "v": "Hand and wrist pain"
    },
    {
      "n": "M18_1",
      "v": "Hand/wrist joint pain: initial imaging",
      "t": "1. In adults with hand and/or wrist joint pain, we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "M18"
    },
    {
      "n": "M18_1_1",
      "v": "Hand/wrist joint: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required, we suggest <b>MRI</b>. (↑)",
      "c": "M18"
    },
    {
      "n": "M18_1_2",
      "v": "Hand/wrist ligament and capsule evaluation, <b>MRI</b> unavailable",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> arthrography for the evaluation of the triangulofibrocartilaginous complex (TFCC), intrinsic ligaments of the wrist or capsule. (↑)",
      "c": "M18"
    },
    {
      "n": "M18_2",
      "v": "Hand/wrist soft tissue pathology / ganglion cyst / synovitis / tenosynovitis: initial imaging",
      "t": "2. In adults with hand and/or wrist pain suspected to be soft tissue related, such as ganglion cyst, synovitis, tenosynovitis, we suggest <b>US</b> as the initial imaging modality. (↑)",
      "c": "M18"
    },
    {
      "n": "M18_2_1",
      "v": "Hand/wrist soft tissue - Alternative imaging",
      "t": "↪ 2.1 As an alternative to <b>US</b>, we suggest <b>MRI</b>. (↑)",
      "c": "M18"
    },
    {
      "n": "M18_3",
      "v": "Hand/wrist pain, Follow-up Imaging for chronic scaphoid fracture or pre-operative evaluation",
      "t": "3. In adults with hand and/or wrist pain, after <b>XR</b>, we suggest <b>CT</b> for evaluation of bone anatomy, chronic scaphoid fracture OR in the context of pre-operative planning. (↑)",
      "c": "M18"
    },
    {
      "n": "M19",
      "v": "MSK pelvis and hip pain"
    },
    {
      "n": "M19_1",
      "v": "Hip pain: initial imaging",
      "t": "1. In adults with hip pain, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M19"
    },
    {
      "n": "M19_2",
      "v": "Hip internal derangement evaluation (labral tear, osteochondral injury, intraarticular body)",
      "t": "2. For evaluation of internal derangement of the hip such as labral tear, osteochondral injury, or intraarticular body and if further investigation is required, we recommend<b>MR</b> arthrography or high-field <b>MRI</b> (i.e., 3T). (↑↑/EPc)",
      "c": "M19"
    },
    {
      "n": "M19_2_1",
      "v": "Hip internal derangement - Alternative imaging",
      "t": "↪ 2.1 If <b>MRI</b> is unavailable or is contraindicated, we suggest <b>CT</b> arthrography for evaluation for internal derangement of the hip. (↑)",
      "c": "M19"
    },
    {
      "n": "M19_3",
      "v": "Deep soft tissue pathology assessment",
      "t": "3. For evaluation of deep soft tissue pathology, after <b>XR</b>, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M19"
    },
    {
      "n": "M19_4",
      "v": "Superficial soft tissue pathology: follow-up imaging",
      "t": "4. For evaluation of superficial soft tissue pathology, after <b>XR</b>, we recommend <b>US</b> or <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M19"
    },
    {
      "n": "M19_5",
      "v": "Hip pain anatomy pre-operative evaluation",
      "t": "5. In adults with hip pain, we suggest <b>CT</b> for evaluation of clinically relevant bone anatomy, typically in the context of pre-operative planning. (EPc)",
      "c": "M19"
    },
    {
      "n": "M19_6",
      "v": "Pelvic pain: initial imaging",
      "t": "6. In adults with musculoskeletal pelvic pain, we suggest <b>XR</b> as the initial imaging modality. (EPc)",
      "c": "M19"
    },
    {
      "n": "M19_6_1",
      "v": "Pelvic pain: follow-up imaging",
      "t": "↪ 6.1 If further investigation is required, we suggest <b>MRI</b> as the next imaging modality. (EPc)",
      "c": "M19"
    },
    {
      "n": "M19_6_2",
      "v": "Pelvic soft tissue pathology assessment",
      "t": "↪ 6.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>US</b> if pathology is favoured to be soft tissue related. (EPc)",
      "c": "M19"
    },
    {
      "n": "M19_6_3",
      "v": "Pelvic bone pathology assessment",
      "t": "↪ 6.3 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> or <b>NM</b> (bone scan) if pathology is favoured to be osseous. (EPc)",
      "c": "M19"
    },
    {
      "n": "M20",
      "v": "Knee pain"
    },
    {
      "n": "M20_1",
      "v": "Knee joint pain: initial imaging",
      "t": "1. In adults with knee joint pain, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M20"
    },
    {
      "n": "M20_1_1",
      "v": "Knee joint pain: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M20"
    },
    {
      "n": "M20_1_2",
      "v": "Knee joint pain: follow-up imaging, <b>MRI</b> unavailable (meniscal tear, chondral defects)",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or contraindicated, we suggest <b>CT</b> arthrography to evaluate for findings such as meniscal tear or chondral defects. (↑)",
      "c": "M20"
    },
    {
      "n": "M20_2",
      "v": "Knee pain, soft tissue: initial imaging",
      "t": "2. In adults with knee pain suspected to be soft tissue related, such as extensor mechanism pathology, bursitis, joint effusion, and popliteal cyst/mass, we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "M20"
    },
    {
      "a": "M20_2",
      "v": "Knee pain (extensor mechanism pathology, bursitis, joint effusion, popliteal cyst/mass): initial imaging"
    },
    {
      "n": "M20_2_1",
      "v": "Knee pain, soft tissue - Alternative imaging",
      "t": "↪ 2.1 As an alternative to <b>US</b>, we recommend <b>MRI</b>. (↑↑)",
      "c": "M20"
    },
    {
      "n": "M20_3",
      "v": "Chronic knee joint pain, bone anatomy - Pre-operative evaluation",
      "t": "3. In adults with chronic knee joint pain, after <b>XR</b>, we suggest <b>CT</b> for evaluation of clinically relevant bone anatomy in scenarios such as patellofemoral maltracking, osteochondral defect, or intraarticular bodies OR in the context of pre-operative planning. (↑ OR EPc)",
      "c": "M20"
    },
    {
      "n": "M21",
      "v": "Ankle pain"
    },
    {
      "n": "M21_1",
      "v": "Ankle pain: initial imaging",
      "t": "1. In adults with ankle pain, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M21"
    },
    {
      "n": "M21_1_1",
      "v": "Ankle pain: follow-up imaging (effusion, tendon abnormality)",
      "t": "↪ 1.1 If further investigation is required for evaluation of effusion or tendon abnormality, we recommend <b>US</b> as the next imaging modality. (↑↑)",
      "c": "M21"
    },
    {
      "n": "M21_1_2",
      "v": "Ankle pain: Further Imaging (ligament and osteochondral evaluation)",
      "t": "↪ 1.2 If further investigation is required to evaluate for findings such as osteochondral lesion or unstable ligament tears, or as an alternative to <b>US</b> for tendon pathology, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M21"
    },
    {
      "n": "M21_2",
      "v": "Ankle pain: osteochondral efect, intraarticular bodies, tarsal coalition / pre-operative evaluation",
      "t": "2. In adults with ankle pain, after <b>XR</b>, we suggest <b>CT</b> for evaluation of clinically significant bone anatomy in scenarios such as osteochondral defect, intraarticular bodies, tarsal coalition OR in the context of pre-operative planning. (↑ OR EPc)",
      "c": "M21"
    },
    {
      "n": "M22",
      "v": "Foot pain"
    },
    {
      "n": "M22_1",
      "v": "Foot pain: initial imaging",
      "t": "1. In adults with foot pain, we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "M22"
    },
    {
      "n": "M22_2",
      "v": "Foot pain, soft tissue related: initial imaging",
      "t": "2. In adults with foot pain suspected to be soft tissue related, such as plantar fasciitis, tendon pathology, bursitis, Morton’s neuroma, we suggest <b>US</b> as the next imaging modality. (↑)",
      "c": "M22"
    },
    {
      "n": "M22_2_1",
      "v": "Foot pain: further investigation",
      "t": "↪ 2.1 If further investigation is required for evaluation for findings such as stress fracture, tarsal coalition, plantar fasciitis, tarsal tunnel syndrome, tendon pathology, or Morton’s neuroma, we suggest <b>MRI</b>. (↑)",
      "c": "M22"
    },
    {
      "a": "M22_2_1",
      "v": "Foot pain: stress fracture, osteochondral defect, tarsal coalition"
    },
    {
      "a": "M22_2_1",
      "v": "Foot pain: plantar fasciitis, tarsal tunnel syndrome, tendon pathology, or Morton's neuroma"
    },
    {
      "n": "M22_3",
      "v": "Foot pain: stress fracture, osteochondral defect or pre-operative evaluation",
      "t": "3. In adults with foot pain, after <b>XR</b>, we suggest <b>CT</b> for evaluation of pathologies such as stress fracture, osteochondral defect OR for evaluation of clinically relevant bone anatomy, typically in the context of pre-operative planning. (↑↑ OR EPc)",
      "c": "M22"
    },
    {
      "n": "M22_4",
      "v": "Foot pain: suspected stress fracture: alternative imaging",
      "t": "4. In adults with foot pain suspected to be a stress fracture, if <b>MRI</b> and <b>CT</b> are unavailable or contraindicated, we suggest <b>NM</b> (bone scan). (↑)",
      "c": "M22"
    },
    {
      "n": "M23",
      "v": "Orthopedic hardware/arthroplasty pain/symptoms"
    },
    {
      "n": "M23_1",
      "v": "Orthopedic hardware/arthroplasty pain: initial imaging",
      "t": "1. In adults with orthopedic hardware/arthroplasty pain or symptoms, we recommend <b>XR</b> as the initial imaging modality, to evaluate for findings such as fracture, dislocation, periprosthetic osteolysis, or hardware fracture/loosening. (↑↑)",
      "c": "M23"
    },
    {
      "n": "M23_1_1",
      "v": "Orthopedic hardware/arthroplasty pain: follow-up imaging",
      "t": "↪ 1.1 If further investigation is required for evaluation of periprosthetic osteolysis or fracture, we recommend <b>CT</b> as the next imaging modality. Metal artifact reduction parameters should be implemented. (↑↑)",
      "c": "M23"
    },
    {
      "n": "M23_1_2",
      "v": "Orthopedic hardware/arthroplasty pain: alternative imaging",
      "t": "↪ 1.2 In adults with orthopedic hardware/arthroplasty pain or symptoms suspicious for infection, loosening, or fracture, we recommend <b>NM</b> (bone scan) when <b>CT</b> is negative, indeterminate, or unavailable. (↑↑)",
      "c": "M23"
    },
    {
      "n": "M23_2",
      "v": "Orthopedic hardware/arthroplasty pain, soft tissue evaluation: follow-up imaging",
      "t": "2. In adults with orthopedic hardware/arthroplasty pain or symptoms suspected to be related to soft tissue pathology, after <b>XR</b>, we recommend <b>MRI</b> as the next imaging modality. Metal artifact reduction sequences should be implemented. (↑↑)",
      "c": "M23"
    },
    {
      "n": "M23_2_1",
      "v": "Orthopedic hardware/arthroplasty pain, soft tissue evaluation: alternative imaging",
      "t": "↪ 2.1 If <b>MRI</b> is not available or contraindicated, we suggest <b>CT</b> (with contrast). (↑)",
      "c": "M23"
    },
    {
      "n": "M23_3",
      "v": "Orthopedic hardware/arthroplasty pain, superficial fluid collections",
      "t": "3. In adults with orthopedic hardware/arthroplasty pain or symptoms, we recommend <b>US</b> to evaluate for superficial fluid collections. (↑↑)",
      "c": "M23"
    },
    {
      "n": "M23_4",
      "v": "Orthopedic hardware/arthroplasty pain, septic arthritis evaluation",
      "t": "4. In adults with orthopedic hardware/arthroplasty pain or symptoms concerning for septic arthritis, after <b>XR</b>, we suggest <b>US</b> or Fluoroscopy to facilitate arthrocentesis. (EPc)",
      "c": "M23"
    },
    {
      "n": "M24",
      "v": "Avascular necrosis/bone infarction"
    },
    {
      "n": "M24_1",
      "v": "Avascular necrosis: initial imaging",
      "t": "1. In adults with suspected avascular necrosis/bone infarction, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M24"
    },
    {
      "n": "M24_1_1",
      "v": "Avascular necrosis: further investigation",
      "t": "↪ 1.1 If further investigation is required for evaluation of avascular necrosis, we recommend <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "M24"
    },
    {
      "n": "M24_1_2",
      "v": "Avascular necrosis: alternative imaging (NM)",
      "t": "↪ 1.2 If <b>MRI</b> is unavailable or is contraindicated, we suggest <b>NM</b> (bone scan). (↑)",
      "c": "M24"
    },
    {
      "n": "M24_1_3",
      "v": "Avascular necrosis: alternative imaging (CT)",
      "t": "↪ 1.3 If <b>MRI</b> and <b>NM</b> (bone scan) are unavailable or contraindicated, we suggest <b>CT</b>. (↑)",
      "c": "M24"
    },
    {
      "n": "M25",
      "v": "Complex regional pain syndrome (CRPS)",
      "t": "Complex regional pain syndrome"
    },
    {
      "n": "M25_1",
      "v": "Complex regional pain syndrome (CRPS): initial imaging",
      "t": "1. In adults with suspected complex regional pain syndrome, we suggest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "M25"
    },
    {
      "n": "M25_1_1",
      "v": "Complex regional pain syndrome (CRPS): further investigation",
      "t": "↪ 1.1 If further investigation is required, we suggest <b>NM</b> (bone scan) as the next imaging modality. (EPc)",
      "c": "M25"
    },
    {
      "n": "M25_1_2",
      "v": "Complex regional pain syndrome (CRPS): alternative imaging",
      "t": "↪ 1.2 If <b>NM</b> is unavailable or is contraindicated, we suggest <b>MRI</b>. (EPc)",
      "c": "M25"
    },
    {
      "n": "CV01",
      "v": "Acute chest pain syndromes / ACS",
      "t": "Acute chest pain syndromes: See ACS subtypes (STEMI, non-STEMI, unstable angina, etc.)"
    },
    {
      "a": "CV01",
      "v": "Myocardial infarction"
    },
    {
      "n": "CV01A",
      "v": "Acute coronary syndrome: ST elevation myocardial infarction (STEMI)",
      "c": "CV01"
    },
    {
      "n": "CV01A_1",
      "v": "STEMI: initial imaging",
      "t": "1. In patients meeting criteria for STEMI (i.e., ECG), we recommend invasive coronary angiography as the initial imaging modality. (↑↑)",
      "c": "CV01A"
    },
    {
      "n": "CV01A_1_1",
      "v": "STEMI: alternative imaging",
      "t": "↪ 1.1 In cases of diagnostic uncertainty OR if immediate invasive coronary angiography is unavailable, we suggest chest <b>XR</b> and bedside TTE/POCUS (if available) to evaluate for other potential causes of chest pain, but this should not delay care. (↑)",
      "c": "CV01A"
    },
    {
      "n": "CV01B",
      "v": "Acute coronary syndrome: non-STEMI",
      "c": "CV01"
    },
    {
      "n": "CV01B_1",
      "v": "Suspected non-STEMI: initial imaging",
      "t": "1. In patients with suspected non-STEMI, we recommend chest <b>XR</b> (to rule out other causes of chest pain) and bedside TTE/POCUS (if available, to evaluate for ventricular function and rule out pericardial effusion) as the initial imaging modalities. (↑↑)",
      "c": "CV01B"
    },
    {
      "n": "CV01B_1_1",
      "v": "Suspected non-STEMI: high-risk evaluation",
      "t": "↪ 1.1 In higher-risk patients, we recommend invasive coronary angiography as the next imaging modality. (↑↑)",
      "c": "CV01B"
    },
    {
      "n": "CV01B_1_2",
      "v": "Suspected non-STEMI, lower-risk patient: next imaging",
      "t": "↪ 1.2 In lower-risk patients, we recommend invasive coronary angiography or CCTA as the next imaging modality, depending on clinical parameters. (↑↑)",
      "c": "CV01B"
    },
    {
      "n": "CV01C",
      "v": "Acute coronary syndrome: unstable angina",
      "c": "CV01"
    },
    {
      "n": "CV01C_1",
      "v": "Suspected unstable angina: initial imaging",
      "t": "1. In patients with suspected unstable angina (i.e., negative cardiac troponin), we recommend chest <b>XR</b> (to rule out other causes of chest pain) and bedside TTE/POCUS (if available, to evaluate for ventricular function and rule out pericardial effusion) as the initial imaging modalities. (↑↑)",
      "c": "CV01C"
    },
    {
      "n": "CV01C_1_1",
      "v": "Suspected unstable angina: risk stratification",
      "t": "↪ 1.1 For assessment of coronary artery disease and for risk stratification, we recommend CCTA. (↑↑)",
      "c": "CV01C"
    },
    {
      "n": "CV01C_2",
      "v": "Suspected unstable angina, refractory: next imaging",
      "t": "2. In patients with suspected unstable angina with ongoing chest pain not relieved with medical management, we recommend invasive coronary angiography. (↑↑)",
      "c": "CV01C"
    },
    {
      "n": "CV01D",
      "v": "Acute aortic syndrome",
      "c": "CV01"
    },
    {
      "n": "CV01D_1",
      "v": "Suspected acute aortic syndrome: initial imaging",
      "t": "1. For patients with suspected acute aortic syndrome, we recommend <b>CT</b>A (preferably cardiac-gated, if available) as the initial imaging modality. (↑↑)",
      "c": "CV01D"
    },
    {
      "n": "CV01D_1_1",
      "v": "Acute aortic syndrome: alternative imaging",
      "t": "↪ 1.1 If <b>CT</b>A is contraindicated, we recommend TEE or <b>MRA</b> as alternative imaging modalities. (↑↑)",
      "c": "CV01D"
    },
    {
      "n": "CV01E",
      "v": "Pulmonary embolism",
      "c": "CV01"
    },
    {
      "n": "CV01E_1",
      "v": "Suspected pulmonary embolism, low/intermediate risk: initial imaging",
      "t": "1. In patients with suspected pulmonary embolism with low or intermediate pretest probability (as determined by a structured risk assessment tool) with a negative D-dimer, we recommend against <b>CT</b>A/ <b>MRA</b>/VQ scan. (↓↓)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_2",
      "v": "Suspected pulmonary embolism, low/intermediate risk: next imaging",
      "t": "2. In patients with suspected pulmonary embolism with low or intermediate pretest probability (as determined by a structured risk assessment tool) with a positive D-dimer test, we recommend <b>CT</b> pulmonary angiography (CTPA) as the initial imaging modality. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_2_1",
      "v": "Suspected pulmonary embolism, low/intermediate risk: alternative imaging",
      "t": "↪ 2.1 If immediate <b>CT</b>PA is not available, we recommend chest <b>XR</b> as the next imaging modality to exclude other causes of chest pain. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_2_2",
      "v": "Suspected pulmonary embolism, low/intermediate risk: alternative imaging",
      "t": "↪ 2.2 If <b>CT</b> pulmonary angiography is contraindicated, we suggest VQ scan or<b>MR</b> pulmonary angiography as an alternative. (↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_3",
      "v": "Suspected pulmonary embolism, high risk: initial imaging",
      "t": "3. In patients with suspected pulmonary embolism and high pretest probability (as determined by a structured risk assessment tool) or in patients with recurrent pulmonary embolism, we recommend <b>CT</b>PA as the initial imaging modality. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_3_1",
      "v": "Suspected pulmonary embolism, high risk: alternative imaging",
      "t": "↪ 3.1 If immediate <b>CT</b>PA is not available, we recommend chest <b>XR</b> as the next imaging modality to exclude other causes of chest pain. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_3_2",
      "v": "Suspected pulmonary embolism, high risk: alternative imaging",
      "t": "↪ 3.2 If <b>CT</b> pulmonary angiography is contraindicated, we suggest VQ scan or<b>MR</b> pulmonary angiography as an alternative. (↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_4",
      "v": "Suspected pulmonary embolism, high risk: initial imaging",
      "t": "4. For pregnant patients with high pretest probability (as determined by a structured risk assessment tool) of pulmonary embolism, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_4_1",
      "v": "Suspected pulmonary embolism, high risk: follow-up imaging",
      "t": "↪ 4.1 If chest <b>XR</b> does not explain the clinical presentation and further imaging is required, we recommend Doppler <b>US</b> as the next imaging modality. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_4_2",
      "v": "Suspected pulmonary embolism, high risk: further investigation",
      "t": "↪ 4.2 If Doppler <b>US</b> is negative, we recommend <b>CT</b>PA or <b>NM</b> (VQ scan) as the next imaging modality. (↑↑)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_5",
      "v": "Suspected chronic thromboembolic pulmonary hypertension: initial imaging",
      "t": "5. In patients with pulmonary hypertension suspected to be secondary to chronic thromboembolic disease (CTEPH), we recommend VQ scan as the initial imaging modality. (EPc)",
      "c": "CV01E"
    },
    {
      "n": "CV01E_5_1",
      "v": "Suspected chronic thromboembolic pulmonary hypertension: alternative imaging",
      "t": "↪ 5.1 If VQ scan is non-diagnostic, indeterminate for chronic pulmonary embolism, or unavailable, we recommend <b>CT</b>PA as an alternative. Dual energy <b>CT</b> technology or iodine subtraction maps can increase <b>CT</b>PA sensitivity to detect chronic pulmonary embolism. (EPc)",
      "c": "CV01E"
    },
    {
      "n": "CV01F",
      "v": "Acute myocarditis",
      "c": "CV01"
    },
    {
      "n": "CV01F_1",
      "v": "Suspected acute myocarditis: initial imaging",
      "t": "1. In patients with suspected acute myocarditis, we recommend TTE followed by cardiac <b>MRI</b> as the initial imaging modalities. (↑↑)",
      "c": "CV01F"
    },
    {
      "n": "CV01F_1_1",
      "v": "Suspected acute myocarditis: coronary evaluation",
      "t": "↪ 1.1 If cardiac <b>MRI</b> does not demonstrate acute myocarditis and if invasive coronary angiography has not been performed, we suggest CCTA as the next imaging modality to exclude obstructive coronary artery disease in appropriately selected patients. (↑)",
      "c": "CV01F"
    },
    {
      "n": "CV01G",
      "v": "Acute pericarditis",
      "c": "CV01"
    },
    {
      "n": "CV01G_1",
      "v": "Suspected acute pericarditis: initial imaging",
      "t": "1. In patients with suspected acute pericarditis, we recommend bedside TTE/POCUS or TEE as the initial imaging modality to assess presence of pericardial thickening, effusion, as well as ventricular function and constrictive physiology. (↑↑)",
      "c": "CV01G"
    },
    {
      "n": "CV01G_1_1",
      "v": "Suspected acute pericarditis: next imaging",
      "t": "↪ 1.1 If further imaging is required to guide management (i.e., pericardiocentesis), we suggest <b>CT</b> (preferably cardiac-gated, if available) as the next imaging modality. (↑)",
      "c": "CV01G"
    },
    {
      "n": "CV01G_1_2",
      "v": "Suspected acute pericarditis: alternative imaging",
      "t": "↪ 1.2 If TTE is inconclusive regarding acute pericarditis or constrictive physiology, we suggest cardiac <b>MRI</b> as an alternative. (↑)",
      "c": "CV01G"
    },
    {
      "n": "CV01H",
      "v": "Non-cardiac chest pain",
      "t": "Non-cardiac chest pain: See CAR Thoracic Diagnostic Imaging Referral Guideline [39]\n- TH02. Non-specific chest pain\n- TH14. Suspected pneumothorax (non-traumatic)\n- TH15. Clinically suspected pleural effusion",
      "c": "CV01"
    },
    {
      "n": "CV02A",
      "v": "Chronic chest pain: Suspected chronic ischemic heart disease"
    },
    {
      "n": "CV02A_1",
      "v": "Suspected chronic ischemic heart disease, established: initial imaging",
      "t": "1. In patients with established chronic ischemic heart disease with recurrent chest pain symptoms despite guideline directed medical therapy and intermediate risk/pre-test probability or known non-obstructive CAD, we suggest anatomical (CCTA), functional (stress <b>NM</b>, stress echo) imaging, or stress<b>MR</b> as the initial imaging modalities. (↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_1_1",
      "v": "Suspected chronic ischemic heart disease, established: further investigation",
      "t": "↪ 1.1 To identify patients who may benefit from further investigation with invasive coronary angiography, we suggest <b>CT</b>-fractional flow reserve (CT-FFR). (↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_2",
      "v": "Suspected chronic ischemic heart disease, established: high risk assessment",
      "t": "2. In patients with established chronic ischemic heart disease with recurrent chest pain symptoms despite guideline directed medical therapy and high risk/pre-test probability, we recommend invasive coronary angiography as the initial imaging modality. (↑↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_3",
      "v": "Suspected chronic ischemic heart disease, established: post-revascularization evaluation",
      "t": "3. In patients with established chronic ischemic heart disease with prior coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafts (CABG) and with recurrent chest pain symptoms, we suggest CCTA to evaluate for stent (especially if stent > 3mm) or graft patency. (↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_3_1",
      "v": "Suspected chronic ischemic heart disease, established: ischemia assessment",
      "t": "↪ 3.1 If evaluation for ischemia to account for symptoms is important, we recommend <b>NM</b> (myocardial perfusion scan). (↑↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_4",
      "v": "Suspected chronic ischemic heart disease, established: low risk screening exclusion",
      "t": "4. In patients with stable chest pain without established ischemic heart disease presenting to the outpatient clinic and at low risk/pre-test likelihood of having obstructive CAD (as determined by a structured assessment tool), routine imaging investigations are not recommended. (↓↓)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_4_1",
      "v": "Suspected chronic ischemic heart disease, established: selected populations CAD screening",
      "t": "↪ 4.1 In selected patient populations, we suggest calcium score <b>CT</b> (for excluding calcified plaque and identifying patients at low likelihood of obstructive CAD) or exercise ECG testing. (↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_5",
      "v": "Suspected chronic ischemic heart disease, non-established: moderate/high risk assessment",
      "t": "5. In patients without established chronic ischemic heart disease with recurrent stable chest pain symptoms and intermediate or high risk/pre-test probability, we recommend CCTA for diagnosis of CAD, risk prognostication and guiding of treatment decisions. (↑↑)",
      "c": "CV02A"
    },
    {
      "n": "CV02A_5_1",
      "v": "Suspected chronic ischemic heart disease, non-established: functional assessment",
      "t": "↪ 5.1 For diagnosis of myocardial ischemia and estimation of risk of major adverse cardiovascular events (MACE), we recommend functional imaging (stress echocardiography or <b>PET</b>/SPECT MPI or CMR). (↑↑)",
      "c": "CV02A"
    },
    {
      "n": "Chronic chest pain: CV02B",
      "v": "Non-cardiac chest pain",
      "t": "See CAR Thoracic Diagnostic Imaging Referral Guideline [39], scenarios:\n- TH02. Non-specific chest pain\n- TH15. Clinically suspected pleural effusion"
    },
    {
      "n": "CV03",
      "v": "Cardiovascular screening and risk stratification (calcium score CT)"
    },
    {
      "n": "CV03_1",
      "v": "Cardiovascular screening, low-risk adults",
      "t": "1. In asymptomatic low-risk adults, we suggest against routine cardiovascular imaging screening and risk stratification. (↓)",
      "c": "CV03"
    },
    {
      "n": "CV03_2",
      "v": "Cardiovascular screening, intermediate/high-risk adults",
      "t": "2. In asymptomatic intermediate-risk adults, we recommend calcium score <b>CT</b> for optimal risk stratification to guide medical management. In high-risk patients reluctant to initiate optimal medical management, calcium score <b>CT</b> can provide useful information for patient counselling. (↑↑)",
      "c": "CV03"
    },
    {
      "n": "CV04",
      "v": "Pericardial syndromes"
    },
    {
      "n": "CV04A",
      "v": "Acute pericarditis",
      "t": "See CV01G. Acute chest pain syndromes (ACPS): Acute pericarditis",
      "c": "CV04"
    },
    {
      "n": "CV04B",
      "v": "Pericardial effusion",
      "c": "CV04"
    },
    {
      "n": "CV04B_1",
      "v": "Suspected pericardial effusion: initial imaging",
      "t": "1. In patients with suspected pericardial effusion, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV04B"
    },
    {
      "n": "CV04B_1_1",
      "v": "Pericardial effusion, suspected effusive constrictive/constrictive physiology: next imaging",
      "t": "↪ 1.1 If there is suspected effusive constrictive/constrictive physiology, we suggest <b>CT</b> (preferably cardiac-gated, if available) as the next imaging modality to evaluate for pericardial thickness, pericardial effusion, and calcification. (↑)",
      "c": "CV04B"
    },
    {
      "n": "CV04B_1_2",
      "v": "Pericardial effusion, suspected effusive constrictive/constrictive physiology: alternative imaging",
      "t": "↪ 1.2 If TTE is inconclusive for effusive constrictive/constrictive physiology, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV04B"
    },
    {
      "n": "CV04B_1_3",
      "v": "Pericardial effusion, suspected effusive constrictive/constrictive physiology: definitive evaluation",
      "t": "↪ 1.3 If cardiac <b>MRI</b> is inconclusive for effusive constrictive/constrictive physiology, we recommend cardiac catheterization. (↑↑)",
      "c": "CV04B"
    },
    {
      "n": "CV04C",
      "v": "Constrictive pericarditis",
      "c": "CV04"
    },
    {
      "n": "CV04C_1",
      "v": "Suspected constrictive pericarditis: initial imaging",
      "t": "1. In patients with suspected constrictive pericarditis, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV04C"
    },
    {
      "n": "CV04C_1_1",
      "v": "Suspected constrictive pericarditis: next imaging",
      "t": "↪ 1.1 If there is suspected constrictive physiology, we suggest <b>CT</b> (preferably cardiac-gated, if available) as the next imaging modality to evaluate for pericardial thickness and calcification. (↑)",
      "c": "CV04C"
    },
    {
      "n": "CV04C_1_2",
      "v": "Suspected constrictive pericarditis: alternative imaging",
      "t": "↪ 1.2 If TTE is inconclusive for constrictive physiology, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV04C"
    },
    {
      "n": "CV04C_1_3",
      "v": "Suspected constrictive pericarditis: definitive evaluation",
      "t": "↪ 1.3 If cardiac <b>MRI</b> is inconclusive for constrictive physiology, we recommend cardiac catheterization. (↑↑)",
      "c": "CV04C"
    },
    {
      "n": "CV05",
      "v": "Intracardiac/pericardial mass"
    },
    {
      "n": "CV05A",
      "v": "Normal variant",
      "c": "CV05"
    },
    {
      "n": "CV05A_1",
      "v": "Suspected intracardiac or pericardial mass detected on CT: initial imaging",
      "t": "1. In patients with a suspected intracardiac or pericardial mass (versus normal variant) detected on chest <b>CT</b>, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV05A"
    },
    {
      "n": "CV05A_1_1",
      "v": "Suspected intracardiac or pericardial mass: next imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV05A"
    },
    {
      "n": "CV05A_1_2",
      "v": "Suspected intracardiac or pericardial mass: alternative imaging",
      "t": "↪ 1.2 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality. (↑↑)",
      "c": "CV05A"
    },
    {
      "n": "CV05A_2",
      "v": "Suspected intracardiac or pericardial mass incidentally detected on TTE: next imaging",
      "t": "2. In patients with a suspected intracardiac or pericardial mass (versus normal variant) incidentally detected on TTE, we recommend cardiac <b>MRI</b> for further characterization. (↑↑)",
      "c": "CV05A"
    },
    {
      "n": "CV05A_2_1",
      "v": "Suspected intracardiac or pericardial mass incidentally detected on TTE: alternative imaging",
      "t": "↪ 2.1 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "CV05A"
    },
    {
      "n": "CV05B",
      "v": "Cardiac Masses",
      "c": "CV05"
    },
    {
      "n": "CV05B_1",
      "v": "Intracardiac or pericardial mass detected on CT: initial imaging",
      "t": "1. In patients with intracardiac or pericardial mass detected on chest <b>CT</b>, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV05B"
    },
    {
      "n": "CV05B_1_1",
      "v": "Intracardiac or pericardial mass detected on CT: next imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV05B"
    },
    {
      "n": "CV05B_1_2",
      "v": "Intracardiac or pericardial mass detected on CT: alternative imaging",
      "t": "↪ 1.2 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality. (↑↑)",
      "c": "CV05B"
    },
    {
      "n": "CV05B_2",
      "v": "Intracardiac or pericardial mass detected on TTE: initial imaging",
      "t": "2. In patients with intracardiac or pericardial mass detected on TTE, we recommend cardiac <b>MRI</b> for further characterization. (↑↑)",
      "c": "CV05B"
    },
    {
      "n": "CV05B_2_1",
      "v": "Intracardiac or pericardial mass detected on TTE: alternative imaging",
      "t": "↪ 2.1 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as the next imaging modality. Cardiac <b>PET</b> may be helpful to guide management. (↑↑)",
      "c": "CV05B"
    },
    {
      "n": "CV06",
      "v": "Suspected valvular disease"
    },
    {
      "n": "CV06A",
      "v": "Aortic valve",
      "c": "CV06"
    },
    {
      "n": "CV06A_1",
      "v": "Suspected aortic valve stenosis: initial imaging",
      "t": "1. In patients with suspected aortic valve stenosis, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_1_1",
      "v": "Suspected aortic valve stenosis: next imaging",
      "t": "↪ 1.1 If the severity of the aortic valve stenosis is unclear (for example in suspected low flow low gradient severe aortic valve stenosis), we recommend calcium score <b>CT</b> of the aortic valve as the next imaging modality. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_1_2",
      "v": "Suspected aortic valve stenosis with suspected pulmonary edema: alternative imaging",
      "t": "↪ 1.2 In patients with suspected aortic valve stenosis where pulmonary edema is suspected, we recommend chest <b>XR</b> as the next imaging modality. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_2",
      "v": "Suspected aortic valve regurgitation: initial imaging",
      "t": "2. In patients with suspected aortic valve regurgitation, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_2_1",
      "v": "Suspected aortic valve regurgitation: next imaging",
      "t": "↪ 2.1 If further imaging is required due to poor acoustic windows or if information about ventricular size and function is required, we recommend cardiac <b>MRI</b> as the next imaging modality or TEE if the mechanism or severity of aortic valve regurgitation is unclear. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_2_2",
      "v": "Suspected aortic valve regurgitation: alternative imaging",
      "t": "↪ 2.2 If <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality for evaluation of ventricular size and function. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_2_3",
      "v": "Suspected aortic valve regurgitation where pulmonary edema is suspected: next imaging",
      "t": "↪ 2.3 In patients with suspected aortic valve regurgitation where pulmonary edema is suspected, we recommend chest <b>XR</b> as the next imaging modality. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_3",
      "v": "Aortic valve disease with suspected infective endocarditis: further evaluation",
      "t": "3. After completing TTE for aortic valve disease, we recommend TEE for suspected infective endocarditis, to further characterize stenosis severity or mechanism of regurgitation, and for ruling out aortic root abscess. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_3_1",
      "v": "Aortic valve disease: suspected aortic root abscess: alternative imaging",
      "t": "↪ 3.1 If there is concern for aortic root abscess and TEE is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_4",
      "v": "Prosthetic valve: suspected infective endocarditis",
      "t": "4. In patients with prosthetic valve, we recommend TTE and TEE for suspected infective endocarditis, to further characterize stenosis severity or mechanism of regurgitation, and for ruling out aortic root abscess. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06A_4_1",
      "v": "Prosthetic valve: suspected aortic root abscess: alternative imaging",
      "t": "↪ 4.1 If there is concern for aortic root abscess and TEE is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV06A"
    },
    {
      "n": "CV06B",
      "v": "Mitral valve",
      "c": "CV06"
    },
    {
      "n": "CV06B_1",
      "v": "Suspected mitral valve stenosis: initial imaging",
      "t": "1. In patients with suspected mitral valve stenosis, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_1_1",
      "v": "Suspected mitral valve stenosis: intervention contemplated",
      "t": "↪ 1.1 If intervention is contemplated or required, we recommend TEE as the next imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_2",
      "v": "Suspected mitral valve stenosis where pulmonary edema is suspected: next imaging",
      "t": "2. In patients with suspected mitral valve stenosis where pulmonary edema is suspected, we recommend chest <b>XR</b> as the next imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_3",
      "v": "Suspected mitral valve regurgitation: initial imaging",
      "t": "3. In patients with suspected mitral valve regurgitation, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_3_1",
      "v": "Suspected mitral valve regurgitation: next imaging",
      "t": "↪ 3.1 If the mechanism or severity is unclear on TTE, we recommend TEE as the next imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_3_2",
      "v": "Suspected mitral valve regurgitation: further imaging",
      "t": "↪ 3.2 If further imaging is required due to poor acoustic windows OR if information about ventricular size and function or confirmation of mitral regurgitation severity is required, we recommend cardiac <b>MRI</b> as the next imaging modality (↑↑). (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06B_4",
      "v": "Suspected mitral valve regurgitation where pulmonary edema is suspected: next imaging",
      "t": "4. In patients with suspected mitral valve regurgitation where pulmonary edema is suspected, we recommend chest <b>XR</b> as the next imaging modality. (↑↑)",
      "c": "CV06B"
    },
    {
      "n": "CV06C",
      "v": "Pulmonary valve",
      "c": "CV06"
    },
    {
      "n": "CV06C_1",
      "v": "Suspected pulmonary valve disease: initial imaging",
      "t": "1. In patients with suspected pulmonary valve disease, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06C_1_1",
      "v": "Suspected pulmonary valve disease: next imaging",
      "t": "↪ 1.1 If further imaging is required due to poor acoustic windows or if information about ventricular size and function is required (e.g., tetralogy of Fallot), we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06C_1_2",
      "v": "Suspected pulmonary valve disease: alternative imaging",
      "t": "↪ 1.2 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality. (↑↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06C_2",
      "v": "Pulmonary valve disease: further evaluation",
      "t": "2. After completing TTE for pulmonary valve disease, we suggest TEE for suspected infective endocarditis, to further characterize stenosis severity or mechanism of regurgitation, and for ruling out abscess. (↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06C_3",
      "v": "Suspected pulmonary valve disease: supra/sub-valvular pathology",
      "t": "3. In patients with suspected pulmonary valve disease where supra and sub-valvular pathologies are possible based on TTE findings, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06C_3_1",
      "v": "Suspected pulmonary valve disease: alternative imaging",
      "t": "↪ 3.1 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality. (↑↑)",
      "c": "CV06C"
    },
    {
      "n": "CV06D",
      "v": "Tricuspid valve",
      "c": "CV06"
    },
    {
      "n": "CV06D_1",
      "v": "Suspected tricuspid valve disease: initial imaging",
      "t": "1. In patients with suspected tricuspid valve disease, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV06D"
    },
    {
      "n": "CV06D_1_1",
      "v": "Suspected tricuspid valve disease: next imaging",
      "t": "↪ 1.1 If further imaging is required due to poor acoustic windows or if information about ventricular size and function is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV06D"
    },
    {
      "n": "CV06D_1_2",
      "v": "Suspected tricuspid valve disease: alternative imaging",
      "t": "↪ 1.2 If cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b> as an alternative imaging modality. (↑↑)",
      "c": "CV06D"
    },
    {
      "n": "CV06D_2",
      "v": "Tricuspid valve disease: further evaluation",
      "t": "2. After completing TTE for tricuspid valve disease, we suggest TEE for suspected infective endocarditis, to further characterize stenosis severity or mechanism of regurgitation, and for ruling out abscess. (↑)",
      "c": "CV06D"
    },
    {
      "n": "CV07",
      "v": "Cardiomyopathy"
    },
    {
      "n": "CV07A",
      "v": "Cardiomyopathy: dilated",
      "c": "CV07"
    },
    {
      "n": "CV07A_1",
      "v": "Suspected dilated cardiomyopathy: initial imaging",
      "t": "1. In patients with suspected dilated cardiomyopathy, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07A_1_1",
      "v": "Suspected dilated cardiomyopathy: evaluate for ischemic cause",
      "t": "↪ 1.1 If ischemic dilated cardiomyopathy is a possibility, we recommend invasive catheter angiography for further evaluation. (↑↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07A_1_2",
      "v": "Suspected dilated cardiomyopathy: alternative to invasive angiography",
      "t": "↪ 1.2 If invasive catheter angiography is unavailable, we recommend CCTA as an alternative. (↑↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07A_1_3",
      "v": "Suspected dilated cardiomyopathy: further imaging",
      "t": "↪ 1.3 If there is no significant obstructive coronary artery disease based on invasive catheter angiography or CCTA results and further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07A_1_4",
      "v": "Suspected dilated cardiomyopathy: alternative to cardiac MRI",
      "t": "↪ 1.4 If information about ventricular size and function is required (and if ventricular size/function is unreliable by TTE) and cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07A_1_5",
      "v": "Suspected dilated cardiomyopathy: further alternatives",
      "t": "↪ 1.5 If cardiac <b>CT</b> is not available, we suggest <b>NM</b> (MUGA). <b>NM</b> (myocardial perfusion scan) may also be helpful to exclude significant ischemia as a cause of dilated cardiomyopathy. (↑)",
      "c": "CV07A"
    },
    {
      "n": "CV07B",
      "v": "Cardiomyopathy: hypertrophic",
      "c": "CV07"
    },
    {
      "n": "CV07B_1",
      "v": "Suspected hypertrophic cardiomyopathy: initial imaging",
      "t": "1. In patients with suspected hypertrophic cardiomyopathy, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV07B"
    },
    {
      "n": "CV07B_1_1",
      "v": "Suspected hypertrophic cardiomyopathy: further imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. <b>MRI</b> can be helpful when echocardiography is inconclusive, when other diagnoses are possible (e.g., amyloidosis, athlete’s heart, storage disease, etc.), or when information about maximum wall thickness, ejection fraction, presence of apical aneurysm or extent of late gadolinium enhancement will influence decision to insert an implantable cardioverter-defibrillator (ICD). (↑↑)",
      "c": "CV07B"
    },
    {
      "n": "CV07B_1_2",
      "v": "Suspected hypertrophic cardiomyopathy: alternative to cardiac MRI",
      "t": "↪ 1.2 If information about ventricular size and function or maximum wall thickness is required AND cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV07B"
    },
    {
      "n": "CV07B_1_3",
      "v": "Suspected hypertrophic cardiomyopathy: evaluate for coronary artery disease",
      "t": "↪ 1.3 To rule out obstructive coronary artery disease as a cause of patient symptoms, we recommend invasive catheter angiography in carefully selected patients. (↑↑)",
      "c": "CV07B"
    },
    {
      "n": "CV07B_1_4",
      "v": "Suspected hypertrophic cardiomyopathy: alternative to invasive angiography",
      "t": "↪ 1.4 If invasive catheter angiography is unavailable, we recommend CCTA as an alternative. (↑↑)",
      "c": "CV07B"
    },
    {
      "n": "CV07C",
      "v": "Cardiomyopathy: restrictive",
      "c": "CV07"
    },
    {
      "n": "CV07C_1",
      "v": "Suspected restrictive/infiltrative cardiomyopathy: initial imaging",
      "t": "1. In patients with suspected restrictive/infiltrative cardiomyopathy, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV07C"
    },
    {
      "n": "CV07C_1_1",
      "v": "Suspected restrictive/infiltrative cardiomyopathy: further imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV07C"
    },
    {
      "n": "CV07C_1_2",
      "v": "Suspected restrictive/infiltrative cardiomyopathy: alternative to cardiac MRI",
      "t": "↪ 1.2 If information about ventricular size and function is required and cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV07C"
    },
    {
      "n": "CV07C_1_3",
      "v": "Suspected cardiac sarcoidosis: next imaging",
      "t": "↪ 1.3 In patients with suspected cardiac sarcoidosis, we recommend FDG-PET-CT. (↑↑)",
      "c": "CV07C"
    },
    {
      "n": "CV07C_1_4",
      "v": "Suspected cardiac amyloidosis",
      "t": "↪ 1.4 In patients with suspected cardiac amyloidosis, if further imaging is required, we recommend <b>NM</b> (pyrophosphate scan) as the next imaging modality. (↑↑)",
      "c": "CV07C"
    },
    {
      "n": "CV07D",
      "v": "Cardiomyopathy: arrhythmogenic",
      "c": "CV07"
    },
    {
      "n": "CV07D_1",
      "v": "Suspected arrhythmogenic cardiomyopathy: initial imaging",
      "t": "1. In patients with suspected arrhythmogenic cardiomyopathy, we recommend TTE as the initial imaging modality. (↑↑)",
      "c": "CV07D"
    },
    {
      "n": "CV07D_1_1",
      "v": "Suspected arrhythmogenic cardiomyopathy: further imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend cardiac <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "CV07D"
    },
    {
      "n": "CV07D_1_2",
      "v": "Suspected arrhythmogenic cardiomyopathy: alternative to cardiac MRI",
      "t": "↪ 1.2 If information about ventricular size and function is required and cardiac <b>MRI</b> is not tolerated, is unavailable, or is contraindicated, we recommend cardiac <b>CT</b>. (↑↑)",
      "c": "CV07D"
    },
    {
      "n": "CV07D_1_3",
      "v": "Suspected arrhythmogenic cardiomyopathy: evaluate for coronary artery disease",
      "t": "↪ 1.3 If obstructive coronary artery disease needs to be ruled out as the cause for arrhythmia, we recommend invasive catheter angiography. (↑↑)",
      "c": "CV07D"
    },
    {
      "n": "CV07D_1_4",
      "v": "Suspected arrhythmogenic cardiomyopathy: alternative to invasive angiography",
      "t": "↪ 1.4 If invasive catheter angiography is unavailable, we recommend CCTA as an alternative. (↑↑)",
      "c": "CV07D"
    },
    {
      "n": "CV08",
      "v": "Aorta"
    },
    {
      "n": "CV08A",
      "v": "Thoraco-abdominal aneurysm",
      "c": "CV08"
    },
    {
      "n": "CV08A_1",
      "v": "Thoracic/thoraco-abdominal aortic aneurysm",
      "t": "1. In patients with thoracic aortic aneurysm identified by TTE, we recommend chest <b>CT</b>A (preferably cardiac-gated) for baseline measurement and surveillance. In younger patients with thoraco-abdominal aortic aneurysm identified by TTE, <b>MRA</b> may be performed for baseline measurement and surveillance. Surgical consultation could be considered for aortas >4.5 cm in size. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08A_2",
      "v": "Suspected abdominal aortic aneurysm: initial imaging",
      "t": "2. In patients without underlying aortopathy with suspected abdominal aortic aneurysm (AAA) based on physical examination, we recommend <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08A_2_1",
      "v": "Abdominal aortic aneurysm, small diameter",
      "t": "↪ 2.1 If <b>US</b> demonstrates aortic diameter between 2.5 and 3.0 cm, we suggest re-evaluation with <b>US</b> after 10 years. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08A_2_2",
      "v": "Abdominal aortic aneurysm, moderate diameter",
      "t": "↪ 2.2 If <b>US</b> demonstrates aortic diameter between 3.0 and 3.9 cm, we recommend repeat <b>US</b> at 3-year intervals. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08A_2_3",
      "v": "Abdominal aortic aneurysm, larger diameter",
      "t": "↪ 2.3 If <b>US</b> demonstrates aortic diameter between 4.0 and 4.9 cm, we recommend annual surveillance with <b>US</b> or <b>CT</b>. Surgical consultation could be considered for aortas >4.5 cm in size. For detailed recommendations for patients with underlying aortopathies and sex specific recommendations, see ACC/AHA guideline [30]. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08A_3",
      "v": "Thoraco-abdominal aneurysm, suspected symptoms",
      "t": "3. In patients with symptoms suspected to be related to thoraco-abdominal aneurysm, we recommend <b>CT</b> with contrast. (↑↑)",
      "c": "CV08A"
    },
    {
      "n": "CV08B",
      "v": "Vasculitis",
      "c": "CV08"
    },
    {
      "n": "CV08B_1",
      "v": "Suspected aortitis",
      "t": "1. In patients with suspected vasculitis involving the aorta (i.e., aortitis), we recommend <b>MRA</b> for baseline measurement and surveillance, especially in young patients. (↑↑)",
      "c": "CV08B"
    },
    {
      "n": "CV08B_1_1",
      "v": "Suspected aortitis: alternative to MRA",
      "t": "↪ 1.1 If <b>MRA</b> is not tolerated, is unavailable, or is contraindicated, we recommend <b>CT</b>A for baseline measurement and surveillance. (↑↑)",
      "c": "CV08B"
    },
    {
      "n": "CV08B_1_2",
      "v": "Suspected aortitis: further imaging if inconclusive",
      "t": "↪ 1.2 If <b>MRA</b> or <b>CT</b>A results are inconclusive regarding disease activity, we suggest FDG-PET-CT or<b>MR</b>-PET. (↑)",
      "c": "CV08B"
    },
    {
      "n": "CV09",
      "v": "Venous thrombosis"
    },
    {
      "n": "CV09_1",
      "v": "Suspected deep vein thrombosis: low pre-test probability and negative D-dimer",
      "t": "1. In patients with suspected deep vein thrombosis with low pre-test probability (as determined by a structured risk assessment tool) AND negative D-dimer, we recommend no imaging. (↓↓)",
      "c": "CV09"
    },
    {
      "n": "CV09_1_1",
      "v": "Suspected deep vein thrombosis: D-dimer unavailable",
      "t": "↪ 1.1 If D-dimer is unavailable, we recommend interim therapeutic anticoagulation and Doppler <b>US</b>. (↑↑)",
      "c": "CV09"
    },
    {
      "n": "CV09_1_2",
      "v": "Suspected deep vein thrombosis: Further imaging if inconclusive",
      "t": "↪ 1.2 If <b>US</b> is inconclusive or of poor quality and further imaging is required, we recommend <b>CT</b>V or<b>MR</b>V as the next imaging modality, with preference for<b>MR</b>V in younger patients. (↑↑)",
      "c": "CV09"
    },
    {
      "n": "CV09_2",
      "v": "Suspected deep vein thrombosis: intermediate/high pre-test probability or positive D-dimer",
      "t": "2. In patients with suspected deep vein thrombosis based with intermediate/high pre-test probability (as determined by a structured risk assessment tool) and/or positive D-dimer, we recommend Doppler <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "CV09"
    },
    {
      "n": "CV09_3",
      "v": "Suspected superficial venous thrombosis",
      "t": "3. In patients with superficial venous thrombosis, we suggest Doppler <b>US</b> as the initial imaging modality. (↑)",
      "c": "CV09"
    },
    {
      "n": "CV10",
      "v": "Peripheral vascular disease"
    },
    {
      "n": "CV10A",
      "v": "Upper and lower extremities",
      "c": "CV10"
    },
    {
      "n": "CV10A_1",
      "v": "Suspected peripheral arterial disease",
      "t": "1. In patients with suspected upper or lower extremity peripheral vascular (arterial) disease based on symptoms or other clinical features and an abnormal ankle-brachial index (ABI < 0.9), we recommend Doppler <b>US</b> for further evaluation. (↑↑)",
      "c": "CV10A"
    },
    {
      "n": "CV10A_1_1",
      "v": "Peripheral arterial disease: further imaging",
      "t": "↪ 1.1 If further imaging is required, we recommend <b>CT</b>A or <b>MRA</b> as the next imaging modality. (↑↑)",
      "c": "CV10A"
    },
    {
      "n": "CV10A_2",
      "v": "Established peripheral arterial disease: recurrent symptoms",
      "t": "2. In patients with established upper or lower extremity peripheral vascular (arterial) disease with recurrent symptoms, we recommend <b>CT</b>A or <b>MRA</b> as the initial imaging modality. (↑↑)",
      "c": "CV10A"
    },
    {
      "n": "CV10B",
      "v": "Vascular malformation",
      "c": "CV10"
    },
    {
      "n": "CV10B_1",
      "v": "Suspected vascular malformation",
      "t": "1. In patients with suspected vascular malformation, to further characterize and guide further management, we recommend time-resolved <b>MRA</b> as the initial imaging modality. In patients presenting with an extremity mass and suspected vascular malformation, Doppler <b>US</b> could be performed as the initial test. (↑↑)",
      "c": "CV10B"
    },
    {
      "n": "CV10B_1_1",
      "v": "Vascular malformation: alternative to time-resolved MRA",
      "t": "↪ 1.1 If <b>MRA</b> is not tolerated, is unavailable, or is contraindicated, we recommend <b>CT</b>A as an alternative. (↑↑)",
      "c": "CV10B"
    },
    {
      "n": "CV10B_1_2",
      "v": "Vascular malformation: high flow lesions",
      "t": "↪ 1.2 To guide further management for high flow vascular malformations, we recommend invasive catheter angiography. (↑↑)",
      "c": "CV10B"
    },
    {
      "n": "CV10C",
      "v": "Entrapment and compression syndromes"
    },
    {
      "n": "CV10C_1",
      "v": "Suspected entrapment or compression syndrome",
      "t": "1. In patients with entrapment and compression syndromes involving the extremities where venous thrombosis is also of concern, we recommend Doppler <b>US</b> as the initial imaging modality. (↑↑)",
      "c": "CV10C"
    },
    {
      "n": "CV10C_1_1",
      "v": "Entrapment/compression syndrome: further imaging if inconclusive",
      "t": "↪ 1.1 If Doppler <b>US</b> is negative or indeterminate and additional imaging is required, we recommend <b>MRA</b> as the next imaging modality. (↑↑)",
      "c": "CV10C"
    },
    {
      "n": "CV10C_1_2",
      "v": "Entrapment/compression syndrome: alternative to MRA",
      "t": "↪ 1.2 If <b>MRA</b> is not tolerated, is unavailable, or is contraindicated, we recommend <b>CT</b>A as an alternative. (↑↑)",
      "c": "CV10C"
    },
    {
      "n": "TH01",
      "v": "Screening/asymptomatic individuals"
    },
    {
      "n": "TH01A",
      "v": "Pre-employment screening",
      "c": "TH01"
    },
    {
      "n": "TH01A_1",
      "v": "Pre-employment screening: routine chest X-ray not recommended",
      "t": "1. For most individuals we recommend against routine chest <b>XR</b> for pre-employment screening, except in specific circumstances (see Recommendation 2). (↓↓)",
      "c": "TH01A"
    },
    {
      "n": "TH01A_2",
      "v": "Pre-employment screening: chest X-ray for high-risk or certain occupations",
      "t": "2. In individuals at high-risk for tuberculosis or in certain occupations (e.g., deep water divers), we recommend routine chest <b>XR</b> if one has not been done recently. (↑↑)",
      "c": "TH01A"
    },
    {
      "n": "TH01A_3",
      "v": "Pre-employment screening: chest X-ray for positive TB test",
      "t": "3. In individuals with positive latent tuberculosis testing, we recommend chest <b>XR</b> to exclude active tuberculosis. (↑↑)",
      "c": "TH01A"
    },
    {
      "n": "TH01B",
      "v": "Asbestos exposure",
      "c": "TH01"
    },
    {
      "n": "TH01B_1",
      "v": "Asymptomatic asbestos exposure: chest X-ray",
      "t": "1. In asymptomatic individuals who have had occupational exposure to asbestos and require imaging for documentation or confirmation of injury, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH01B"
    },
    {
      "n": "TH01B_1_1",
      "v": "Asbestos exposure: next imaging",
      "t": "↪ 1.1 In individuals with equivocal chest <b>XR</b> and/or a high clinical suspicion for occupational lung disease, we recommend high-resolution <b>CT</b> as the next imaging modality. (EPc)",
      "c": "TH01B"
    },
    {
      "n": "TH01C",
      "v": "Routine in-patient radiographs"
    },
    {
      "n": "TH01C_1",
      "v": "Inpatients: routine chest X-ray not recommended",
      "t": "1. In in-patients, we recommend against routine chest <b>XR</b>. (EPc)",
      "c": "TH01C"
    },
    {
      "n": "TH02",
      "v": "Non-specific chest pain"
    },
    {
      "n": "TH02_1",
      "v": "Non-specific chest pain: chest X-ray as initial imaging",
      "t": "1. In stable patients where imaging is clinically or biochemically indicated, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH02"
    },
    {
      "n": "TH02_1_1",
      "v": "Non-specific chest pain: further investigation",
      "t": "↪ 1.1 If the chest <b>XR</b> is normal or equivocal, we suggest that further investigations should be guided after clinical consideration of etiology. (꙳)",
      "c": "TH02"
    },
    {
      "n": "TH03",
      "v": "Hospital admission for non-thoracic conditions"
    },
    {
      "n": "TH03_1",
      "v": "Hospital admission for non-thoracic conditions: no routine chest X-ray",
      "t": "1. In patients being admitted to hospital for non-thoracic conditions, we recommend against routine chest <b>XR</b>. (↓↓)",
      "c": "TH03"
    },
    {
      "n": "TH04",
      "v": "Long-term care admission"
    },
    {
      "n": "TH04_1",
      "v": "Long-term care admission",
      "t": "1. In individuals who are being admitted to long-term care, we recommend referring to the local practice guidelines. (↑↑)",
      "c": "TH04"
    },
    {
      "n": "TH05",
      "v": "Routine pre-operative"
    },
    {
      "n": "TH05_1",
      "v": "Pre-op non-cardiothoracic surgery",
      "t": "1. In patients undergoing non-cardiothoracic surgery, we suggest against routine pre-operative chest <b>XR</b>. (↓)",
      "c": "TH05"
    },
    {
      "n": "TH05_2",
      "v": "Pre-op cardiothoracic surgery",
      "t": "2. In patients undergoing cardiothoracic surgery, we suggest routine pre-operative chest <b>XR</b>. (↑)",
      "c": "TH05"
    },
    {
      "n": "TH05_3",
      "v": "Pre-op for frail elderly or cardiorespiratory disease",
      "t": "3. In frail elderly patients and in those with significant cardiorespiratory disease, we suggest routine pre-operative chest <b>XR</b>. (↑)",
      "c": "TH05"
    },
    {
      "n": "TH06",
      "v": "Post-interventional chest procedure"
    },
    {
      "n": "TH06_1",
      "v": "Post-chest procedure",
      "t": "1. In patients who have undergone a chest procedure, including cardiothoracic surgery, we suggest routine post-interventional chest <b>XR</b> in situations where clinical judgement may not be sensitive to potential complications, including post transthoracic interventions (e.g., lung biopsy, central line, nasogastric tube, endotracheal tube placement, thoracentesis, chest tube, etc.). (↑)",
      "c": "TH06"
    },
    {
      "n": "TH07",
      "v": "Upper respiratory tract infections"
    },
    {
      "n": "TH07_1",
      "v": "Uncomplicated upper respiratory infection",
      "t": "1. In patients with uncomplicated upper respiratory tract infection, we recommend against chest <b>XR</b>. (↓↓)",
      "c": "TH07"
    },
    {
      "n": "TH07_2",
      "v": "Suspected pneumonia, acute tracheobronchitis: initial imaging",
      "t": "2. In patients with clinical suspicion of pneumonia, acute tracheobronchitis with other comorbid conditions, we suggest chest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "TH07"
    },
    {
      "n": "TH08",
      "v": "Acute exacerbation of asthma"
    },
    {
      "n": "TH08_1",
      "v": "Acute asthma exacerbation without complications",
      "t": "1. In patients with acute asthma exacerbation without clinical concern for complications, we suggest against chest <b>XR</b>. (↓)",
      "c": "TH08"
    },
    {
      "n": "TH08_2",
      "v": "Acute asthma exacerbation with complications",
      "t": "2. In patients with acute asthma exacerbation with clinical concern for complications꙳, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH08"
    },
    {
      "n": "TH09",
      "v": "Acute exacerbation of COPD"
    },
    {
      "n": "TH09_1",
      "v": "Acute COPD exacerbation without hospital referral",
      "t": "1. In patients with acute exacerbation of COPD who do not need a referral to hospital, we suggest against routine chest <b>XR</b>. (↓)",
      "c": "TH09"
    },
    {
      "n": "TH09_2",
      "v": "Acute COPD exacerbation with hospital referral",
      "t": "2. In patients with acute exacerbation of COPD who are referred to hospital, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH09"
    },
    {
      "n": "TH09_2_1",
      "v": "Acute COPD exacerbation with negative or indeterminate X-Ray",
      "t": "↪ 2.1 In situations where chest <b>XR</b> is negative or indeterminate where there is persistent clinical concern or management might be altered, we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH09"
    },
    {
      "n": "TH10",
      "v": "Suspected pneumonia"
    },
    {
      "a": "TH10",
      "v": "Suspected CAP"
    },
    {
      "n": "TH10_1",
      "v": "Suspected pneumonia with high pre-test probability",
      "t": "1. In stable outpatients with suspected pneumonia with a very high pre-test probability of pneumonia and when a chest <b>XR</b> would not alter management, we suggest against chest <b>XR</b>. (↓)",
      "c": "TH10"
    },
    {
      "n": "TH10_2",
      "v": "Suspected pneumonia with abnormal vital signs",
      "t": "2. In patients with abnormal vital signs secondary to suspected pneumonia, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH10"
    },
    {
      "n": "TH10_2_1",
      "v": "Severe or complicated pneumonia",
      "t": "↪ 2.1 In patients with severe or complicated pneumonia (e.g., lung abscess, suspected empyema, or possible atypical organisms), we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH10"
    },
    {
      "a": "TH11",
      "v": "CAP follow-up"
    },
    {
      "n": "TH11",
      "v": "Pneumonia follow-up"
    },
    {
      "n": "TH11_1",
      "v": "Pneumonia with clinical recovery",
      "t": "1. In patients with clinical recovery of pneumonia, we do not recommend follow-up chest <b>XR</b>. (↓↓)",
      "c": "TH11"
    },
    {
      "n": "TH11_2",
      "v": "Pneumonia with persistent symptoms or risk factors",
      "t": "2. In patients with persistent symptoms or physical signs of pneumonia or in those at higher risk of malignancy꙳, we suggest follow-up chest <b>XR</b> at least six weeks after treatment. (↑)",
      "c": "TH11"
    },
    {
      "n": "TH11_2_1",
      "v": "Pneumonia with no resolution within expected time",
      "t": "↪ 2.1 In patients with no radiological or clinical resolution of pneumonia within the expected time (e.g., 8-12 weeks), we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH11"
    },
    {
      "n": "TH12",
      "v": "Immunosuppressed patient with respiratory symptoms/febrile neutropenia"
    },
    {
      "n": "TH12_1",
      "v": "Immunosuppressed with respiratory symptoms/febrile neutropenia",
      "t": "1. In immunosuppressed patients with respiratory symptoms/febrile neutropenia, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH12"
    },
    {
      "n": "TH12_1_1",
      "v": "Immunosuppressed with normal X-Ray and high clinical suspicion",
      "t": "↪ 1.1 If chest <b>XR</b> is normal, equivocal, or inconclusive and there remains high clinical suspicion for pulmonary infection, we recommend low-dose chest <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "TH12"
    },
    {
      "n": "TH13",
      "v": "Chronic cough"
    },
    {
      "n": "TH13_1",
      "v": "Chronic cough: initial imaging",
      "t": "1. In patients with chronic cough, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH13"
    },
    {
      "n": "TH13_1_1",
      "v": "Chronic cough: normal exam and X-Ray, no cause identified",
      "t": "↪ 1.1 In patients with normal physical exam and chest <b>XR</b>, we suggest against routine chest <b>CT</b>. (↓)",
      "c": "TH13"
    },
    {
      "n": "TH13_1_2",
      "v": "Chronic cough: normal exam and X-Ray, suspected underlying condition",
      "t": "↪ 1.2 In patients with normal physical exam and chest <b>XR</b> and common causes of chronic cough have been excluded but there is ongoing clinical concern for etiology such as bronchiectasis, early interstitial lung disease, or lung cancer, we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH13"
    },
    {
      "n": "TH14",
      "v": "Suspected pneumothorax (non-traumatic)"
    },
    {
      "n": "TH14_1",
      "v": "Suspected pneumothorax: initial imaging",
      "t": "1. In patients with suspected pneumothorax, we recommend erect inspiratory chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH14"
    },
    {
      "n": "TH14_1_1",
      "v": "Pneumothorax: further imaging",
      "t": "↪ 1.1 If chest <b>XR</b> findings are equivocal or indeterminate and further imaging is required, we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH14"
    },
    {
      "n": "TH15",
      "v": "Clinically suspected pleural effusion"
    },
    {
      "n": "TH15_1",
      "v": "Clinically suspected pleural effusion: initial imaging",
      "t": "1. In patients with clinically suspected pleural effusion, we recommend chest <b>XR</b> or bedside <b>US</b> (if available) as the initial imaging modality. (↑↑)",
      "c": "TH15"
    },
    {
      "n": "TH15_1_1",
      "v": "Clinically suspected pleural effusion: further imaging",
      "t": "↪ 1.1 If further imaging is required, we suggest chest <b>CT</b> as the next imaging modality. (↑)",
      "c": "TH15"
    },
    {
      "n": "TH16",
      "v": "Hemoptysis"
    },
    {
      "n": "TH16_1",
      "v": "Trace hemoptysis: initial imaging",
      "t": "1. In patients with trace hemoptysis, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH16"
    },
    {
      "n": "TH16_1_1",
      "v": "Trace hemoptysis: risk factors or persistent/recurrent",
      "t": "↪ 1.1 In patients with risk factors꙳ or persistent/recurrent unexplained hemoptysis, we recommend chest <b>CT</b> as a complementary imaging modality. (↑↑)",
      "c": "TH16"
    },
    {
      "n": "TH16_2",
      "v": "Clinically significant hemoptysis",
      "t": "2. In patients with clinically significant hemoptysis, we recommend chest <b>XR</b>* and chest <b>CT</b> as the initial imaging modalities. (↑↑)",
      "c": "TH16"
    },
    {
      "n": "TH17",
      "v": "Chronic dyspnea of non-cardiovascular origin"
    },
    {
      "n": "TH17_1",
      "v": "Chronic dyspnea of non-cardiovascular origin",
      "t": "1. In patients with chronic dyspnea of non-cardiovascular origin, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH17"
    },
    {
      "n": "TH17_1_1",
      "v": "Chronic dyspnea with normal X-Ray and ongoing clinical concern",
      "t": "↪ 1.1 If chest <b>XR</b> is normal and clinical concern remains, any decision for further imaging should be based on clinical grounds. (EPc)",
      "c": "TH17"
    },
    {
      "n": "TH18",
      "v": "Suspected interstitial lung disease"
    },
    {
      "a": "TH18",
      "v": "Suspected ILD / pulmonary fibrosis / IPF / DPLD / restrictive lung disease"
    },
    {
      "n": "TH18_1",
      "v": "Suspected interstitial lung disease: initial imaging",
      "t": "1. In patients with suspected interstitial lung disease, we recommend chest <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "TH18"
    },
    {
      "n": "TH18_1_1",
      "v": "Suspected interstitial lung disease: further imaging",
      "t": "↪ 1.1 If further imaging is required, given that chest <b>XR</b> do not rule out interstitial lung disease, we recommend high-resolution <b>CT</b> (HRCT) as the next imaging modality. (↑↑)",
      "c": "TH18"
    },
    {
      "n": "TH19",
      "v": "Incidental lung nodule"
    },
    {
      "n": "TH19_1",
      "v": "Incidental lung nodule",
      "t": "1. In patients with an incidental lung nodule detected on chest <b>CT</b>꙳, we recommend following the Fleischner Society Guidelines for Management of Incidental Pulmonary Nodules Detected on <b>CT</b> Images. Fleischner Society Guidelines: https://doi.org/10.1148/radiol.2017161659 (↑↑)",
      "c": "TH19"
    },
    {
      "n": "TH20",
      "v": "Suspected mediastinal lesion"
    },
    {
      "n": "TH20_1",
      "v": "Suspected mediastinal lesion: initial imaging",
      "t": "1. In patients with suspected mediastinal lesion, we recommend chest <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "TH20"
    },
    {
      "n": "TH20_1_1",
      "v": "Suspected mediastinal lesion: further imaging",
      "t": "↪ 1.1 If further imaging is required to evaluate local invasion or to characterize tissue composition, we recommend chest <b>MRI</b> as the next imaging modality. (↑↑)",
      "c": "TH20"
    },
    {
      "n": "TH21",
      "v": "Suspected mediastinal lymphadenopathy"
    },
    {
      "n": "TH21_1",
      "v": "Suspected mediastinal lymphadenopathy: initial imaging",
      "t": "1. In patients with suspected mediastinal lymphadenopathy, we recommend chest <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "TH21"
    },
    {
      "n": "TH22",
      "v": "Elevated diaphragm on chest radiograph (CXR)"
    },
    {
      "n": "TH22_1",
      "v": "Elevated diaphragm on CXR, suspected phrenic nerve palsy",
      "t": "1. In patients with elevated diaphragm on chest <b>XR</b> and suspected phrenic nerve palsy, we suggest fluoroscopy or <b>US</b> as the initial imaging modality. The imaging modality may vary based on regional practice preferences and resource availability. (↑)",
      "c": "TH22"
    },
    {
      "n": "GI01",
      "v": "Dysphagia/ dyspepsia"
    },
    {
      "n": "GI01_1",
      "v": "Dysphagia",
      "t": "1. In patients with dysphagia, we suggest <b>fluoroscopy</b> (esophagram or upper GI series) as the initial imaging modality. (↑)",
      "c": "GI01"
    },
    {
      "n": "GI01_2",
      "v": "Dyspepsia of unknown cause",
      "t": "2. In patients with dyspepsia of unknown cause, we suggest <b>fluoroscopy upper GI series</b> as the initial imaging modality. (↑)",
      "c": "GI01"
    },
    {
      "n": "GI01_3",
      "v": "Dyspepsia with suspected gastric motility abnormality",
      "t": "3. In patients with dyspepsia if there is clinical suspicion of abnormal gastric motility, we suggest <b>NM scintigraphy</b> (gastric emptying) as the initial imaging modality. (↑)",
      "c": "GI01"
    },
    {
      "n": "GI02",
      "v": "Acute nonlocalized abdominal pain"
    },
    {
      "n": "GI02_1",
      "v": "Acute nonlocalized abdominal pain, suspected uncomplicated infectious colitis",
      "t": "1. In patients with suspected uncomplicated acute infectious colitis presenting with acute nonlocalized abdominal pain, we recommend against imaging in the absence of other concerning clinical and/or biochemical findings. (↓↓)",
      "c": "GI02"
    },
    {
      "n": "GI02_2",
      "v": "Acute nonlocalized abdominal pain in non-pregnant patients",
      "t": "2. In non-pregnant patients with acute nonlocalized abdominal pain and/or bowel obstruction, we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "GI02"
    },
    {
      "n": "GI02_2_1",
      "v": "Acute nonlocalized abdominal pain, equivocal or inconclusive X-Ray",
      "t": "↪ 2.1 If <b>XR</b> is equivocal and/or further investigation is required, we recommend <b>CT abdomen and pelvis</b> as the next imaging modality. (↑↑)",
      "c": "GI02"
    },
    {
      "n": "GI02_3",
      "v": "Acute nonlocalized abdominal pain in pregnant patients",
      "t": "3. In pregnant patients with acute nonlocalized abdominal pain, we recommend <b>US abdomen and pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI02"
    },
    {
      "n": "GI03",
      "v": "Acute localized abdominal pain"
    },
    {
      "n": "GI03A",
      "v": "Epigastric pain",
      "c": "GI03"
    },
    {
      "n": "GI03A_1",
      "v": "Epigastric pain with probable esophageal or gastric etiology",
      "t": "1. In patients with epigastric pain with probable esophageal or gastric etiology, we suggest <b>fluoroscopy upper GI series</b> as the initial imaging modality. (↑)",
      "c": "GI03A"
    },
    {
      "n": "GI03A_1_1",
      "v": "Epigastric pain without upper GI etiology",
      "t": "↪ 1.1 If upper GI series is not available, we suggest a <b>CT abdomen and pelvis</b>. (↑)",
      "c": "GI03A"
    },
    {
      "n": "GI03A_2",
      "v": "Epigastric pain without probable esophageal or gastric etiology",
      "t": "2. In patients with epigastric pain without probable esophageal or gastric etiology, we suggest a <b>CT abdomen and pelvis</b> as the initial imaging modality. (↑)",
      "c": "GI03A"
    },
    {
      "a": "GI03B",
      "v": "RUQ pain"
    },
    {
      "n": "GI03B",
      "v": "Right upper quadrant pain",
      "c": "GI03"
    },
    {
      "n": "GI03B_1",
      "v": "Right upper quadrant pain, suspected hepatobiliary disease",
      "t": "1. In patients with right upper quadrant pain (suspected hepatobiliary disease), we recommend against <b>XR</b>. (↓↓)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_2",
      "v": "Right upper quadrant pain, suspected hepatobiliary disease",
      "t": "2. In patients with right upper quadrant pain (suspected hepatobiliary disease), we recommend <b>US abdomen</b> as the initial imaging modality. (↑↑)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_2_1",
      "v": "Right upper quadrant pain, suspected hepatobiliary disease, equivocal ultrasound",
      "t": "↪ 2.1 If <b>US</b> is not available or further investigation is required, we suggest <b>CT abdomen and pelvis</b> or <b>NM</b> (HIDA scan) as the next imaging modality. (↑)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_2_2",
      "v": "Right upper quadrant pain, suspected choledocolithiasis, equivocal ultrasound",
      "t": "↪ 2.2 If <b>US</b> is indeterminate and the clinical/biochemical presentation is strongly suggestive of choledocolithiasis, we suggest consultation for endoscopic <b>US</b>/ERCP and/or<b>MR</b>CP. (↑)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_3",
      "v": "Right upper quadrant pain, non-hepatobiliary disease",
      "t": "3. In patients with right upper quadrant pain (non-hepatobiliary disease), we recommend <b>US abdomen</b> as the initial imaging modality. (EPc)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_3_1",
      "v": "Right upper quadrant pain, non-hepatobiliary disease, equivocal ultrasound",
      "t": "↪ 3.1 If <b>US</b> is indeterminate, we suggest <b>CT abdomen and pelvis</b> as the next imaging modality. (EPc)",
      "c": "GI03B"
    },
    {
      "n": "GI03B_3_2",
      "v": "Right upper quadrant pain, non-hepatobiliary disease, ultrasound and <b>CT</b> unavailable",
      "t": "↪ 3.2 If <b>US</b> and <b>CT</b> are not immediately available, we suggest <b>XR</b> as the initial imaging modality. (EPc)",
      "c": "GI03B"
    },
    {
      "a": "GI03C",
      "v": "RLQ pain"
    },
    {
      "n": "GI03C",
      "v": "Right lower quadrant pain",
      "c": "GI03"
    },
    {
      "n": "GI03C_1",
      "v": "Right lower quadrant pain in younger patients",
      "t": "1. In younger patients with right lower quadrant pain, we recommend <b>US</b> as the initial imaging modality, as per ALARA principles. (↑↑)",
      "c": "GI03C"
    },
    {
      "n": "GI03C_1_1",
      "v": "Right lower quadrant pain in non-pregnant younger patients, negative or inconclusive ultrasound",
      "t": "↪ 1.1 In non-pregnant patients, if <b>US</b> is negative for appendicitis or inconclusive and further imaging is required, we suggest <b>CT abdomen and pelvis</b> as the next imaging modality. (↑)",
      "c": "GI03C"
    },
    {
      "n": "GI03C_1_2",
      "v": "Right lower quadrant pain in pregnant patients, inconclusive ultrasound",
      "t": "↪ 1.2 In pregnant patients, if <b>US</b> is inconclusive for appendicitis, we recommend <b>MR abdomen and pelvis</b> as the next imaging modality. (↑↑)",
      "c": "GI03C"
    },
    {
      "n": "GI03C_2",
      "v": "Right lower quadrant pain in older patients",
      "t": "2. In older patients with right lower quadrant pain, we recommend <b>CT abdomen and pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI03C"
    },
    {
      "a": "GI03D",
      "v": "LUQ pain"
    },
    {
      "n": "GI03D",
      "v": "Left upper quadrant pain",
      "c": "GI03"
    },
    {
      "n": "GI03D_1",
      "v": "Left upper quadrant pain, concern for reflux or ulcer",
      "t": "1. In patients with left upper quadrant pain (concern for reflux or ulcer), we suggest against <b>fluoroscopic upper GI series</b>. (↓)",
      "c": "GI03D"
    },
    {
      "n": "GI03D_2",
      "v": "Left upper quadrant pain, unknown etiology",
      "t": "2. In patients with left upper quadrant pain (unknown etiology), we recommend <b>US abdomen</b> as the initial imaging modality. (EPc)",
      "c": "GI03D"
    },
    {
      "n": "GI03D_2_1",
      "v": "Left upper quadrant pain, unknown etiology, equivocal ultrasound",
      "t": "↪ 2.1 If <b>US</b> is indeterminate, we suggest <b>CT abdomen and pelvis</b> as the next imaging modality. (EPc)",
      "c": "GI03D"
    },
    {
      "n": "GI03D_2_2",
      "v": "Left upper quadrant pain, unknown etiology, ultrasound and <b>CT</b> unavailable",
      "t": "↪ 2.2 If <b>US</b> and <b>CT</b> are not immediately available, we suggest <b>XR</b> as the initial imaging modality. (EPc)",
      "c": "GI03D"
    },
    {
      "a": "GI03E",
      "v": "LLQ pain"
    },
    {
      "n": "GI03E",
      "v": "Left lower quadrant pain",
      "c": "GI03"
    },
    {
      "n": "GI03E_1",
      "v": "Left lower quadrant pain, suspected diverticulitis",
      "t": "1. In patients with left lower quadrant pain (suspected diverticulitis), we recommend <b>CT abdomen and pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI03E"
    },
    {
      "n": "GI03E_2",
      "v": "Left lower quadrant pain, other intraabdominal cause",
      "t": "2. In patients with left lower quadrant pain (other intraabdominal cause), we recommend <b>XR</b> as the initial imaging modality. (EPc)",
      "c": "GI03E"
    },
    {
      "n": "GI03E_2_1",
      "v": "Left lower quadrant pain, other cause, negative or inconclusive X-Ray",
      "t": "↪ 2.1 If <b>XR</b> is negative or indeterminate and further imaging is required, we suggest <b>CT abdomen and pelvis</b> as the next imaging modality. (EPc)",
      "c": "GI03E"
    },
    {
      "n": "GI03E_2_2",
      "v": "Left lower quadrant pain, other cause in younger patients or <b>CT</b> contraindicated",
      "t": "↪ 2.2 In younger patients or if <b>CT</b> is contraindicated, we suggest <b>US</b> as the next imaging modality. (EPc)",
      "c": "GI03E"
    },
    {
      "n": "GI04",
      "v": "Chronic abdominal pain"
    },
    {
      "n": "GI04_1",
      "v": "Chronic abdominal pain meeting IBS criteria",
      "t": "1. In patients who meet the diagnostic criteria for irritable bowel syndrome, we recommend against imaging in the absence of concerning clinical and/or biochemical findings. (↓↓)",
      "c": "GI04"
    },
    {
      "n": "GI04_2",
      "v": "Chronic abdominal pain: <b>MRI</b> not recommended",
      "t": "2. In patients with chronic abdominal pain, we recommend against<b>MRI</b> as an imaging modality due to limited sensitivity and specificity. (EPc)",
      "c": "GI04"
    },
    {
      "n": "GI04_3",
      "v": "Chronic abdominal pain: initial imaging",
      "t": "3. In patients with chronic abdominal pain, we recommend <b>CT abdomen and pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI04"
    },
    {
      "n": "GI04_3_1",
      "v": "Chronic abdominal pain, ultrasound alternative if <b>CT</b> unavailable",
      "t": "↪ 3.1 If <b>CT</b> is unavailable, we suggest <b>US abdomen</b> as an alternative imaging modality, accepting its limited scope of assessment compared to <b>CT</b>. (↑)",
      "c": "GI04"
    },
    {
      "n": "GI04_4",
      "v": "Chronic abdominal pain, suspected chronic mesenteric ischemia",
      "t": "4. In patients with chronic abdominal pain (suspected chronic mesenteric ischemia), we recommend <b>CTA abdomen and pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI04"
    },
    {
      "n": "GI05",
      "v": "Inflammatory bowel disease"
    },
    {
      "n": "GI05_1",
      "v": "Inflammatory bowel disease, endoscopy-negative",
      "t": "1. In endoscopy-negative patients with suspected inflammatory bowel disease, we recommend against <b>fluoroscopy small bowel follow through</b>. (↓↓)",
      "c": "GI05"
    },
    {
      "n": "GI05_2",
      "v": "Suspected inflammatory bowel disease in younger patients",
      "t": "2. In younger patients with suspected inflammatory bowel disease, we recommend <b>MR enterography</b> as the initial imaging modality. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_2_1",
      "v": "Suspected inflammatory bowel disease in younger patients,<b>MR</b> enterography contraindicated or unavailable",
      "t": "↪ 2.1 If<b>MR</b> enterography is contraindicated or unavailable, we suggest <b>CT enterography</b>. (↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_3",
      "v": "Suspected inflammatory bowel disease in older patients",
      "t": "3. In older patients with suspected inflammatory bowel disease, we recommend <b>CT enterography</b> as the initial imaging modality. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_3_1",
      "v": "Suspected inflammatory bowel disease in older patients, <b>CT enterography</b> intolerant",
      "t": "↪ 3.1 If <b>CT enterography</b> cannot be tolerated, we suggest <b>CT abdomen and pelvis</b>. (↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_4",
      "v": "Acute exacerbation of inflammatory bowel disease in younger patients",
      "t": "4. In younger patients with suspected acute exacerbation of known inflammatory bowel disease, we recommend <b>MR enterography</b> as the initial imaging modality. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_4_1",
      "v": "Acute exacerbation of inflammatory bowel disease in younger patients,<b>MR</b>/<b>CT enterography</b> unavailable",
      "t": "↪ 4.1 If<b>MR</b> enterography is contraindicated or unavailable, we suggest <b>CT enterography</b>. (↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_4_2",
      "v": "Acute exacerbation of inflammatory bowel disease in younger patients,<b>MR</b>/<b>CT enterography</b> intolerant",
      "t": "↪ 4.2 If<b>MR</b>/<b>CT enterography</b> cannot be tolerated, we recommend <b>CT abdomen and pelvis</b>. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_5",
      "v": "Acute exacerbation of inflammatory bowel disease in older patients",
      "t": "5. In older patients with inflammatory bowel disease with suspected acute exacerbation, we recommend <b>CT enterography</b> as the initial imaging modality. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI05_5_1",
      "v": "Acute exacerbation of inflammatory bowel disease in older patients, <b>CT enterography</b> intolerant",
      "t": "↪ 5.1 If <b>CT enterography</b> cannot be tolerated, we recommend <b>CT abdomen and pelvis</b>. (↑↑)",
      "c": "GI05"
    },
    {
      "n": "GI06",
      "v": "Acute gi bleeding"
    },
    {
      "n": "GI06A",
      "v": "Upper acute GI bleeding",
      "c": "GI06"
    },
    {
      "n": "GI06A_1",
      "v": "Acute upper GI bleeding",
      "t": "1. In patients with acute upper GI bleeding, we recommend <b>CT</b>A or Diagnostic angiography as the initial imaging modality. (↑↑)",
      "c": "GI06A"
    },
    {
      "n": "GI06B",
      "v": "Lower acute GI bleeding",
      "c": "GI06"
    },
    {
      "n": "GI06B_1",
      "v": "Acute lower GI bleeding",
      "t": "1. In patients with acute lower GI bleeding, we recommend <b>CT</b>A or Diagnostic angiography as the initial imaging modality. (↑↑)",
      "c": "GI06B"
    },
    {
      "n": "GI06B_1_1",
      "v": "Acute lower GI bleeding, negative <b>CT</b>A",
      "t": "↪ 1.1 If <b>CT</b>A is negative or inconclusive, we suggest <b>NM</b> scintigraphy (RBC scan). (↑)",
      "c": "GI06B"
    },
    {
      "n": "GI07",
      "v": "Chronic GI bleeding/anemia"
    },
    {
      "n": "GI07_1",
      "v": "Chronic GI bleeding,<b>MR</b> enterography not recommended",
      "t": "1. In patients with suspected chronic GI bleeding, we suggest against routine use of <b>MR enterography</b> due to limited spatial resolution. (↓)",
      "c": "GI07"
    },
    {
      "n": "GI07_2",
      "v": "Chronic GI bleeding",
      "t": "2. In patients with suspected chronic GI bleeding, we recommend <b>CT enterography</b> as the initial imaging modality. (↑↑)",
      "c": "GI07"
    },
    {
      "n": "GI07_2_1",
      "v": "Chronic GI bleeding, CT enterography intolerant",
      "t": "↪ 2.1 If <b>CT enterography</b> cannot be tolerated, we suggest <b>CT abdomen and pelvis</b>. (↑)",
      "c": "GI07"
    },
    {
      "n": "GI07_2_2",
      "v": "Chronic GI bleeding, negative CT enterography",
      "t": "↪ 2.2 If <b>CT enterography</b> is negative and further investigation is required, we suggest <b>NM scintigraphy</b> (RBC and/or Meckel's study) ± capsule endoscopy as the next imaging modality. (↑)",
      "c": "GI07"
    },
    {
      "n": "GI08A_1",
      "v": "Acute abnormal liver biochemistry, ultrasound",
      "t": "1. In patients with acute abnormal liver biochemistry, we recommend <b>US abdomen</b> as the initial imaging modality. (↑↑)",
      "c": "GI08A"
    },
    {
      "n": "GI08A_1_1",
      "v": "Acute abnormal liver biochemistry, CT/MRI if ultrasound inconclusive",
      "t": "↪ 1.1 If <b>US</b> is inconclusive or if further investigation is required, we suggest <b>CT abdomen</b> or <b>MR abdomen</b> (equivalent alternatives) as the next imaging modality. (↑)",
      "c": "GI08A"
    },
    {
      "n": "GI08B_1",
      "v": "Chronic abnormal liver biochemistry, ultrasound",
      "t": "1. In patients with chronic abnormal liver biochemistry, we recommend <b>US abdomen</b> as the initial imaging modality, ideally with the use of a high frequency linear probe to assess the hepatic surface. (↑↑)",
      "c": "GI08B"
    },
    {
      "n": "GI08B_1_1",
      "v": "Chronic abnormal liver biochemistry, MRI if further investigation required",
      "t": "↪ 1.1 If further investigation is required, we recommend <b>MR abdomen</b> as the next imaging modality. (↑↑)",
      "c": "GI08B"
    },
    {
      "n": "GI08B_1_2",
      "v": "Chronic abnormal liver biochemistry, CT if MRI unavailable",
      "t": "↪ 1.2 If<b>MR</b> abdomen is contraindicated or unavailable, we suggest <b>CT abdomen</b>. (↑)",
      "c": "GI08B"
    },
    {
      "n": "GI08B_2",
      "v": "Chronic abnormal liver biochemistry, ultrasound with shear wave elastography",
      "t": "2. In noncirrhotic patients with chronic abnormal liver biochemistry, if available, we suggest <b>US shear wave elastography</b> in addition to <b>US</b> abdomen to diagnose, follow, or stage occult hepatic fibrosis. (↑)",
      "c": "GI08B"
    },
    {
      "n": "GI08B_2_1",
      "v": "Chronic abnormal liver biochemistry, MR elastography if ultrasound inconclusive",
      "t": "↪ 2.1 If <b>US</b> shear wave elastography is not available or inconclusive and imaging is required, we suggest <b>MR elastography</b>. (↑)",
      "c": "GI08B"
    },
    {
      "n": "GI09A_1",
      "v": "Acute pancreatitis, no imaging for diagnosis",
      "t": "1. As per the revised Atlanta Criteria, in patients who meet the diagnostic criteria for acute pancreatitis, we recommend against imaging for the purpose of diagnosis. (↓↓)",
      "c": "GI09A"
    },
    {
      "n": "GI09A_2",
      "v": "Acute pancreatitis due to gallstones, ultrasound",
      "t": "2. In patients with suspected acute pancreatitis due to gallstones, we recommend <b>US abdomen</b> as the initial imaging modality. (↑↑)",
      "c": "GI09A"
    },
    {
      "n": "GI09A_2_1",
      "v": "Acute pancreatitis, MRI if further investigation required",
      "t": "↪ 2.1 If further investigation is required, we recommend <b>MR abdomen with<b>MR</b>CP</b> as the next imaging modality. (↑↑)",
      "c": "GI09A"
    },
    {
      "n": "GI09A_3",
      "v": "Complicated acute pancreatitis, imaging per guidelines",
      "t": "3. In patients with suspected complicated sub-acute pancreatitis, we recommend imaging as per the revised Atlanta Criteria. (↑↑)",
      "c": "GI09A"
    },
    {
      "n": "GI09B_1",
      "v": "Suspected chronic pancreatitis, <b>CT</b>",
      "t": "1. In patients with suspected chronic pancreatitis, we recommend <b>CT abdomen</b> as the initial imaging modality. (↑↑)",
      "c": "GI09B"
    },
    {
      "n": "GI09B_1_1",
      "v": "Chronic pancreatitis, GI referral if CT negative",
      "t": "↪ 1.1 If <b>CT</b> is negative, we suggest GI referral ± endoscopic <b>US</b>. (↑)",
      "c": "GI09B"
    },
    {
      "n": "GI09B_2",
      "v": "Known chronic pancreatitis, MRI",
      "t": "2. In patients with known chronic pancreatitis, we recommend <b>MR abdomen with<b>MR</b>CP</b> for any required follow-up imaging. (↑↑)",
      "c": "GI09B"
    },
    {
      "n": "GI09B_2_1",
      "v": "Known chronic pancreatitis, CT if MRI unavailable",
      "t": "↪ 2.1 If<b>MR</b> abdomen is contraindicated or unavailable, we suggest <b>CT abdomen</b>. (↑)",
      "c": "GI09B"
    },
    {
      "n": "GI10_1",
      "v": "Suspected perianal fistula, no CT",
      "t": "1. In patients with suspected perianal fistula, we recommend against <b>CT pelvis</b>. (↓↓)",
      "c": "GI10"
    },
    {
      "n": "GI10_2",
      "v": "Suspected perianal fistula: initial imaging",
      "t": "2. In patients with suspected perianal fistula, we recommend <b>MR pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_2_1",
      "v": "Suspected perianal fistula, endoanal ultrasound if <b>MRI</b> unavailable",
      "t": "↪ 2.1 If <b>MRI</b> is not available or contraindicated, we suggest <b>endoanal <b>US</b> as an alternative imaging modality. (↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_3",
      "v": "Suspected perianal abscess, <b>MRI</b>",
      "t": "3. In patients with suspected perianal abscess, we recommend <b>MR pelvis</b> as the initial imaging modality. (↑↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_3_1",
      "v": "Suspected perianal abscess, endoanal ultrasound if <b>MRI</b> unavailable",
      "t": "↪ 3.1 If <b>MRI</b> is not available or contraindicated, we suggest <b>endoanal <b>US</b> as an alternative imaging modality. (↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_3_2",
      "v": "Large perianal abscess, <b>CT</b> if <b>MRI</b>/US unavailable",
      "t": "↪ 3.2 In patients with suspected large perianal abscess, if <b>MRI</b> or <b>US</b> is not available or contraindicated, we suggest <b>CT pelvis</b> as an alternative imaging modality. (↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_4",
      "v": "Suspected anovesicular/anovaginal fistula, <b>CT</b>",
      "t": "4. In patients with suspected anovesicular or anovaginal fistula, we recommend <b>CT pelvis</b>. (↑↑)",
      "c": "GI10"
    },
    {
      "n": "GI10_4_1",
      "v": "Suspected anovesicular/anovaginal fistula, <b>MRI</b> alternative",
      "t": "↪ 4.1 In patients with suspected anovesicular or anovaginal fistula, we suggest <b>MR pelvis</b> as an alternative imaging modality. (↑)",
      "c": "GI10"
    },
    {
      "n": "GI11_1",
      "v": "Uncomplicated acute infectious colitis, no imaging",
      "t": "1. In patients with suspected uncomplicated acute infectious colitis presenting with acute nonlocalized abdominal pain, we recommend against imaging in the absence of other concerning clinical and/or biochemical findings. (↓↓)",
      "c": "GI11"
    },
    {
      "n": "GI11_2",
      "v": "Diarrhea of unknown cause: initial imaging",
      "t": "2. In patients with diarrhea (unknown cause), we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "GI11"
    },
    {
      "n": "GI11_2_1",
      "v": "Diarrhea, <b>CT</b> if X-Ray inconclusive",
      "t": "↪ 2.1 If <b>XR</b> is inconclusive, we suggest specialist consultation (e.g., gastroenterology, general surgery) and/or <b>CT</b> abdomen and pelvis. (↑)",
      "c": "GI11"
    },
    {
      "n": "GI12_1",
      "v": "Fecal incontinence with constipation, no imaging",
      "t": "1. In patients with fecal incontinence (clinically diagnosed constipation), we recommend against imaging in the absence of other concerning clinical and/or biochemical findings. (↓↓)",
      "c": "GI12"
    },
    {
      "n": "GI12_2",
      "v": "Fecal incontinence, X-Ray",
      "t": "2. In patients with fecal incontinence (clinically indeterminate for constipation), we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "GI12"
    },
    {
      "n": "GI12_3",
      "v": "Fecal incontinence, suspected cauda equina, <b>MRI</b>",
      "t": "3. In patients with fecal incontinence (suspected cauda equina), we recommend<b>MR</b> lumbar spine as the initial imaging modality. (EPc)",
      "c": "GI12"
    },
    {
      "n": "GI12_4",
      "v": "Fecal incontinence, suspected pelvic floor dysfunction, dynamic <b>MRI</b>",
      "t": "4. In patients with fecal incontinence (suspected pelvic floor dysfunction), we suggest dynamic<b>MR</b> pelvic floor. (EPc)",
      "c": "GI12"
    },
    {
      "n": "GI12_4_1",
      "v": "Fecal incontinence, pelvic floor dysfunction, fluoroscopic defecography if <b>MRI</b> unavailable",
      "t": "↪ 4.1 If <b>MRI</b> is not available or contraindicated, we suggest fluoroscopic defecography. (EPc)",
      "c": "GI12"
    },
    {
      "n": "GI13_1",
      "v": "Suspected/known foreign body ingestion: initial imaging",
      "t": "1. In patients with suspected or known foreign body ingestion, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "GI13"
    },
    {
      "n": "GI13_1_1",
      "v": "Foreign body ingestion, <b>CT</b> if X-Ray concerning",
      "t": "↪ 1.1 If <b>XR</b> is suspicious for obstruction or perforation, we suggest <b>CT</b> abdomen and pelvis as the next imaging modality. (↑)",
      "c": "GI13"
    },
    {
      "n": "GI13_1_2",
      "v": "Foreign body ingestion, <b>CT</b> if X-Ray negative and further management needed",
      "t": "↪ 1.2 If <b>XR</b> is negative and additional management is being considered, we suggest <b>CT</b> abdomen and pelvis as the next imaging modality. (↑)",
      "c": "GI13"
    },
    {
      "n": "OG1",
      "v": "1st trimester assessment"
    },
    {
      "n": "OG1_1",
      "v": "No ultrasound for pregnancy confirmation",
      "t": "1. In patients with suspected pregnancy, we recommend against <b>US</b> for pregnancy confirmation. (↓↓)",
      "c": "OG1"
    },
    {
      "n": "OG1_2",
      "v": "Transabdominal ultrasound for 1st trimester assessment",
      "t": "2. In patients in the 1st trimester with confirmed intrauterine pregnancy, we recommend transabdominal <b>US</b> as the initial imaging modality for the following: pregnancy dating, to assess fetal number, chorionicity and amnionicity in multiple gestations, measurement of nuchal translucency (in single and multiple gestations), screening for select major anatomical abnormalities (such as anencephaly), and in patients with suspected complications of early pregnancy. (↑↑)",
      "c": "OG1"
    },
    {
      "n": "OG1_2_1",
      "v": "Transvaginal ultrasound if transabdominal is suboptimal",
      "t": "↪ 2.1 If transabdominal <b>US</b> is indeterminate or suboptimal for these clinical indications, we recommend transvaginal <b>US</b> as an adjunct. (↑↑)",
      "c": "OG1"
    },
    {
      "n": "OG1_3",
      "v": "No Doppler without clinical indication in 1st trimester",
      "t": "3. In patients in the 1st trimester with a viable or potentially viable intrauterine pregnancy, we suggest not using Doppler as an adjunct to <b>US</b> without a clear clinical indication. (↓)",
      "c": "OG1"
    },
    {
      "n": "OG1_4",
      "v": "Combined transabdominal and transvaginal ultrasound for suspected ectopic or pregnancy of unknown location",
      "t": "4. In patients in the 1st trimester with a positive pregnancy test and a suspected PUL or ectopic pregnancy, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. The uterus should be thoroughly scanned for the presence of a gestational sac, and in its absence, then the adnexa should be thoroughly scanned for the presence of a mass. (↑↑)",
      "c": "OG1"
    },
    {
      "n": "OG1_4_1",
      "v": "Repeat ultrasound if initial results are inconclusive",
      "t": "↪ 4.1 If results are initially inconclusive, we recommend close clinical and biochemical assessment with follow-up repeat <b>US</b> assessment. (↑↑)",
      "c": "OG1"
    },
    {
      "n": "OG2",
      "v": "2nd trimester assessment"
    },
    {
      "n": "OG2_1",
      "v": "Transabdominal ultrasound for routine 2nd trimester screening",
      "t": "1. In patients in the 2nd trimester of pregnancy, typically between 18-20 weeks, we recommend routine screening with transabdominal <b>US</b>, for evaluation of fetal anatomy, fetal growth, and general assessment of the placenta. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_1_1",
      "v": "Doppler ultrasound for fetal evaluation",
      "t": "↪ 1.1 Where indicated, in the evaluation of fetal growth and well-being, characterization of complex anatomy, and placental and cord assessment, we recommend Doppler as an adjunct. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_1_2",
      "v": "MRI for complex fetal conditions",
      "t": "↪ 1.2 For complex fetal conditions, if <b>US</b> is indeterminate or if further investigation is required, we suggest <b>MRI</b>. Timing of the <b>MRI</b> may be determined based on clinical indication. (↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_2",
      "v": "Combined transabdominal and transvaginal ultrasound for suspected low-lying or invasive placenta",
      "t": "2. In patients in the 2nd trimester of pregnancy with suspected low location of the placenta or invasive placentation, we recommend a combined transabdominal and transvaginal <b>US</b> approach. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_2_1",
      "v": "Doppler ultrasound for placental assessment",
      "t": "↪ 2.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_2_2",
      "v": "MRI for suspected invasive placentation",
      "t": "↪ 2.2 For suspected invasive placentation, if <b>US</b> is indeterminate or if further investigation is required, we suggest <b>MRI</b>. (↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_3",
      "v": "Transvaginal ultrasound for cervical assessment in high-risk pregnancies",
      "t": "3. In patients in the 2nd trimester with a history of pre-term birth, or with other risk factors for pre-term birth, and in patients with suspected preterm labour, we recommend transvaginal <b>US</b> for assessment of the cervix. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_3_1",
      "v": "Transperineal ultrasound if transvaginal is not feasible",
      "t": "↪ 3.1 If transvaginal <b>US</b> is declined or is not feasible, we recommend transperineal <b>US</b> as an alternative. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_4",
      "v": "Combined transabdominal and transvaginal ultrasound for 2nd trimester vaginal bleeding",
      "t": "4. In patients in the 2nd trimester experiencing vaginal bleeding, we recommend a combined transabdominal and transvaginal <b>US</b> approach. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_4_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 4.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG2"
    },
    {
      "n": "OG2_5",
      "v": "Fetal echocardiography if indicated after routine anatomy scan",
      "t": "5. Following the routine anatomy scan, if risk factors are identified and/or fetal cardiac screening examination is abnormal, we suggest fetal echocardiography <b>US</b>. (↑)",
      "c": "OG2"
    },
    {
      "n": "OG3",
      "v": "3rd trimester assessment"
    },
    {
      "n": "OG3_1",
      "v": "Transabdominal ultrasound for 3rd trimester assessment if no prior scans",
      "t": "1. In patients in the 3rd trimester who have not received a 1st or 2nd trimester diagnostic <b>US</b>, we recommend transabdominal <b>US</b> for general assessment of the pregnancy. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_1_1",
      "v": "Doppler and/or transvaginal ultrasound as clinically indicated",
      "t": "↪ 1.1 We recommend Doppler and/or transvaginal <b>US</b> as adjuncts, as clinically indicated. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_2",
      "v": "Transabdominal ultrasound surveillance for high-risk 3rd trimester pregnancies",
      "t": "2. In high-risk 3rd trimester pregnancies, including multifetal pregnancy, we recommend transabdominal <b>US</b> surveillance to monitor fetal growth and well-being. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_2_1",
      "v": "Doppler and/or transvaginal ultrasound as clinically indicated",
      "t": "↪ 2.1 We recommend Doppler and/or transvaginal <b>US</b> as adjuncts, as clinically indicated. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_2_2",
      "v": "MRI for complex fetal conditions",
      "t": "↪ 2.2 For complex fetal conditions, if <b>US</b> is indeterminate or if further investigation is required, we suggest <b>MRI</b>. Timing of the <b>MRI</b> may be determined based on clinical indication. (↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_3",
      "v": "Transvaginal ultrasound to assess placental location in known low-lying/previa",
      "t": "3. In patients diagnosed with low-lying placenta or placenta previa in the 2nd trimester, we recommend a transvaginal <b>US</b> to reassess placental location by the mid-3rd trimester. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_3_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 3.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_4",
      "v": "Combined transabdominal and transvaginal ultrasound for suspected invasive placentation",
      "t": "4. In patients in the 3rd trimester of pregnancy with suspected invasive placentation, we recommend a combined transabdominal and transvaginal <b>US</b> approach. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_4_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 4.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_4_2",
      "v": "MRI if further investigation required",
      "t": "↪ 4.2 If further investigation is required, we suggest <b>MRI</b>. (↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_5",
      "v": "Combined transabdominal and transvaginal ultrasound for 3rd trimester vaginal bleeding",
      "t": "5. In patients in the 3rd trimester of pregnancy experiencing vaginal bleeding, we recommend a combined transabdominal and transvaginal <b>US</b> approach. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG3_5_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 5.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG3"
    },
    {
      "n": "OG4",
      "v": "Post-partum (up to 6 weeks)"
    },
    {
      "n": "OG4_1",
      "v": "Combined transabdominal and transvaginal ultrasound for postpartum hemorrhage",
      "t": "1. In patients with early and/or late post-partum hemorrhage, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging modality. (↑↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_1_2",
      "v": "MRI if ultrasound is indeterminate",
      "t": "↪ 1.2 If <b>US</b> is indeterminate or further investigation is required, we suggest <b>MRI</b> as the next imaging modality. (↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_1_3",
      "v": "Clinical observation with ultrasound if <b>MRI</b> is unavailable",
      "t": "↪ 1.3 If <b>MRI</b> is unavailable or contraindicated, we suggest close clinical observation with follow-up transabdominal and transvaginal <b>US</b>. (EPc)",
      "c": "OG4"
    },
    {
      "n": "OG4_2",
      "v": "CT for suspected intraabdominal bleeding with postpartum hemorrhage",
      "t": "2. In patients with early and/or late post-partum hemorrhage where there is clinical concern for intraabdominal bleeding, we suggest <b>CT</b> to confirm, localize, and assess for the presence of active bleeding. (↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_3",
      "v": "Combined transabdominal and transvaginal ultrasound for postpartum infection",
      "t": "3. In patients with suspected or confirmed post-partum infection, we recommend combined transabdominal and transvaginal <b>US</b> approach as the initial imaging modality to exclude retained products of conception and assess for complications of infection. (↑↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_3_1",
      "v": "CT or <b>MRI</b> if ultrasound is indeterminate",
      "t": "↪ 3.1 If <b>US</b> is indeterminate or further investigation is required, we suggest <b>CT</b> or <b>MRI</b> as the next imaging modality depending on the clinical situation. (↑)",
      "c": "OG4"
    },
    {
      "n": "OG4_3_2",
      "v": "Clinical monitoring and follow-up ultrasound if <b>CT</b>/<b>MR</b>I unavailable",
      "t": "↪ 3.2 If <b>CT</b> and <b>MRI</b> are unavailable or contraindicated, we suggest close clinical monitoring and follow-up <b>US</b>. (EPc)",
      "c": "OG4"
    },
    {
      "n": "OG5",
      "v": "Recurrent pregnancy loss (1st trimester)"
    },
    {
      "n": "OG5_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients with recurrent 1st trimester pregnancy loss, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG5"
    },
    {
      "n": "OG5_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We suggest Doppler as an adjunct. (↑)",
      "c": "OG5"
    },
    {
      "n": "OG5_1_2",
      "v": "MRI if ultrasound is negative, indeterminate, or complex abnormalities",
      "t": "↪ 1.2 If <b>US</b> is negative, indeterminate, or if additional workup of complex abnormalities identified on <b>US</b> is required, we recommend <b>MRI</b> pelvis as the next imaging technique. (↑↑)",
      "c": "OG5"
    },
    {
      "n": "OG5_2",
      "v": "MRI, 3-D ultrasound, or SIS for suspected Müllerian/intracavitary abnormalities",
      "t": "2. In patients with suspected Müllerian duct or intracavitary abnormalities based on initial assessment, we suggest <b>MRI</b>, 3-D <b>US</b>, or SIS for further characterization. (↑)",
      "c": "OG5"
    },
    {
      "n": "OG6",
      "v": "Infertility assessment"
    },
    {
      "n": "OG6_1",
      "v": "Transabdominal and/or transvaginal ultrasound as initial imaging",
      "t": "1. In patients with infertility, we recommend transabdominal <b>US</b> and/or transvaginal <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "OG6"
    },
    {
      "n": "OG6_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We suggest Doppler as an adjunct. (↑)",
      "c": "OG6"
    },
    {
      "n": "OG6_1_2",
      "v": "3-D ultrasound, SIS, or <b>MRI</b> if ultrasound of endometrium is indeterminate",
      "t": "↪ 1.2 If initial assessment by <b>US</b> is indeterminate or if additional workup of the endometrium is required, we recommend 3-D <b>US</b>, SIS, or <b>MRI</b> as the next imaging technique. (↑↑)",
      "c": "OG6"
    },
    {
      "n": "OG6_1_3",
      "v": "MRI if ultrasound assessment of adnexa is indeterminate",
      "t": "↪ 1.3 If <b>US</b> assessment of the adnexa is indeterminate or if additional workup of the adnexa is required, we recommend <b>MRI</b> as the next imaging technique. (↑↑)",
      "c": "OG6"
    },
    {
      "n": "OG6_2",
      "v": "SIS or HSG for tubal patency assessment",
      "t": "2. In patients with infertility, for the assessment of tubal patency, we recommend SIS or HSG. (↑↑)",
      "c": "OG6"
    },
    {
      "n": "OG6_3",
      "v": "Ultrasound to assess for varicocele in male infertility",
      "t": "3. In the investigation of the male factor infertility, we recommend <b>US</b> as the initial imaging technique to assess for varicoceles. (↑↑)",
      "c": "OG6"
    },
    {
      "n": "OG7",
      "v": "Evaluation of adnexal mass"
    },
    {
      "n": "OG7_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients with suspected adnexal mass with no acute symptoms, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG7"
    },
    {
      "n": "OG7_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG7"
    },
    {
      "n": "OG7_1_2",
      "v": "MRI if ultrasound is indeterminate",
      "t": "↪ 1.2 If <b>US</b> is indeterminate or further investigation is required, we recommend <b>MRI</b> as the next imaging technique. (↑↑)",
      "c": "OG7"
    },
    {
      "n": "OG8",
      "v": "Evaluation of acute pelvic pain of presumed gynecologic origin"
    },
    {
      "n": "OG8_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients with acute pelvic pain of presumed gynecologic origin, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG8"
    },
    {
      "n": "OG8_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG8"
    },
    {
      "n": "OG8_1_2",
      "v": "Repeat combined ultrasound if initial is indeterminate",
      "t": "↪ 1.2 If <b>US</b> is indeterminate or further investigation is required and immediate management is not indicated, we recommend follow-up combined transabdominal and transvaginal <b>US</b> approach. (↑↑)",
      "c": "OG8"
    },
    {
      "n": "OG8_1_3",
      "v": "CT in beta-HCG negative patients if further investigation required",
      "t": "↪ 1.3 If further investigation is required, we suggest <b>CT</b> (in beta-HCG negative patients). (↑)",
      "c": "OG8"
    },
    {
      "n": "OG8_1_4",
      "v": "Pelvic <b>MRI</b> in pregnant patients or for problem-solving",
      "t": "↪ 1.4 In pregnant patients and for problem-solving, where indicated, we suggest pelvic <b>MRI</b>. (↑↑)",
      "c": "OG8"
    },
    {
      "n": "OG9",
      "v": "Evaluation of chronic pelvic pain of presumed gynecologic origin"
    },
    {
      "n": "OG9_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients with chronic pelvic pain of presumed gynecologic origin, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG9"
    },
    {
      "n": "OG9_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We recommend Doppler as an adjunct. (↑↑)",
      "c": "OG9"
    },
    {
      "n": "OG9_1_2",
      "v": "CT in beta-HCG negative patients if further investigation required",
      "t": "↪ 1.2 If further investigation is required, we suggest <b>CT</b> (in beta-HCG negative patients). (↑)",
      "c": "OG9"
    },
    {
      "n": "OG9_1_3",
      "v": "Pelvic <b>MRI</b> in pregnant patients or for problem-solving",
      "t": "↪ 1.3 In pregnant patients and for problem-solving, where indicated, we suggest pelvic <b>MRI</b>. (↑)",
      "c": "OG9"
    },
    {
      "n": "OG10",
      "v": "Pelvic floor evaluation in females",
      "t": "No recommendation. The role of imaging in evaluation of the pelvic floor is an evolving science and further research is required to guide recommendations in this field."
    },
    {
      "n": "OG11",
      "v": "Disorders of menstruation"
    },
    {
      "n": "OG11_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients with abnormal uterine bleeding, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG11"
    },
    {
      "n": "OG11_1_1",
      "v": "Doppler ultrasound as an adjunct",
      "t": "↪ 1.1 We suggest Doppler as an adjunct. (↑)",
      "c": "OG11"
    },
    {
      "n": "OG11_1_2",
      "v": "SIS if further endometrial investigation required",
      "t": "↪ 1.2 If further investigation of the endometrium is required, we recommend SIS as the next imaging technique. (↑↑)",
      "c": "OG11"
    },
    {
      "n": "OG11_1_3",
      "v": "MRI if sonographic investigations are inconclusive",
      "t": "↪ 1.3 If sonographic investigations are inconclusive or unavailable, we recommend <b>MRI</b>. (↑↑)",
      "c": "OG11"
    },
    {
      "n": "OG11_2",
      "v": "No routine ultrasound for ovarian morphology in PCOS",
      "t": "2. For patients diagnosed on clinical and biochemical grounds with polycystic ovarian syndrome, we do not recommend the routine use of <b>US</b> for evaluation of ovarian morphology. (↓↓)",
      "c": "OG11"
    },
    {
      "n": "OG11_2_1",
      "v": "Transvaginal ultrasound if clinical/biochemical indices are equivocal",
      "t": "↪ 2.1 If clinical and biochemical indices are equivocal, we recommend transvaginal <b>US</b> to assess ovarian morphology. (↑↑)",
      "c": "OG11"
    },
    {
      "n": "OG12",
      "v": "Localization of IUCD"
    },
    {
      "n": "OG12_1",
      "v": "Combined transabdominal and transvaginal ultrasound as initial imaging",
      "t": "1. In patients where localization of an intra-uterine contraceptive device (IUCD) is required, we recommend a combined transabdominal and transvaginal <b>US</b> approach as the initial imaging technique. (↑↑)",
      "c": "OG12"
    },
    {
      "n": "OG12_1_1",
      "v": "3-D ultrasound as an adjunct if available",
      "t": "↪ 1.1 We suggest 3-D <b>US</b> as an adjunct, where available. (↑)",
      "c": "OG12"
    },
    {
      "n": "OG12_1_2",
      "v": "X-Ray if IUCD not seen on ultrasound",
      "t": "↪ 1.2 If IUCD is not seen in the uterus on <b>US</b>, we recommend <b>XR</b> of the abdomen and pelvis as the next imaging technique. (↑↑)",
      "c": "OG12"
    },
    {
      "n": "T01",
      "v": "Acute head trauma in adults",
      "t": "Acute head trauma in adults"
    },
    {
      "a": "T01",
      "v": "Acute concussion / mild traumatic brain injury / MTBI in adults"
    },
    {
      "n": "T01_1",
      "v": "Acute head injury: initial imaging",
      "t": "1. In adults who have sustained an acute head injury who meet criteria for imaging according to a clinical decision rule (e.g., CCHR, NEXUS II, etc.), we recommend <b>CT head</b> as the initial imaging modality. [see page 9 for CCHR and NEXUS criteria] (↑↑)",
      "c": "T01"
    },
    {
      "n": "T01_2",
      "v": "Acute head injury: No X-Ray except as problem-solving tool",
      "t": "2. In adults who have sustained an acute head injury, we recommend against <b>XR</b>, except as a problem-solving tool (e.g., gunshot wounds). (↓↓)",
      "c": "T01"
    },
    {
      "n": "T02",
      "v": "Acute head trauma in children",
      "t": "Acute head trauma in children"
    },
    {
      "n": "T02_1",
      "v": "Acute head trauma in children: initial imaging",
      "t": "1. In children who have sustained an acute head injury who meet criteria for imaging according to a clinical decision rule (e.g., PECARN, CATCH), we recommend <b>CT head</b> as the initial imaging modality. [see page 10 for PECARN and CATCH criteria] (↑↑)"
    },
    {
      "n": "T02_2",
      "v": "Acute head trauma in children: No X-Ray except as problem-solving tool",
      "t": "2. In children who have sustained an acute head injury, we recommend against <b>XR</b>, except as a problem-solving tool (e.g., gunshot wounds, non-accidental trauma) (↓↓)",
      "c": "T02"
    },
    {
      "n": "T03",
      "v": "Acute facial trauma"
    },
    {
      "n": "T03_1",
      "v": "Acute facial trauma: initial imaging",
      "t": "1. In patients with facial trauma, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T03"
    },
    {
      "n": "T03_2",
      "v": "Acute facial trauma, isolated facial trauma",
      "t": "2. In patients with isolated facial trauma*, we recommend against <b>XR</b>. (↓↓)",
      "c": "T03"
    },
    {
      "n": "T03_2_1",
      "v": "Acute facial trauma: suspected mandibular fracture",
      "t": "↪ 2.1 *In patients with suspected mandibular fracture, we suggest <b>OPG</b> if <b>CT</b> is not available. (↑)",
      "c": "T03"
    },
    {
      "n": "T04",
      "v": "Acute orbital trauma"
    },
    {
      "n": "T04_1",
      "v": "Acute orbital trauma: initial imaging",
      "t": "1. In patients with orbital trauma, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T04"
    },
    {
      "n": "T04_2",
      "v": "Acute orbital trauma: No x-ray unless query metallic foreign body",
      "t": "2. In patients with orbital trauma, we recommend against <b>XR</b>, except when the clinical question is exclusion of retained metallic foreign body. (↓↓)",
      "c": "T04"
    },
    {
      "n": "T05",
      "v": "Suspected cervical spine trauma in adults"
    },
    {
      "a": "T05",
      "v": "Suspected c-spine trauma in adults"
    },
    {
      "n": "T05_1",
      "v": "Suspected cervical spine trauma in adults: initial imaging",
      "t": "1. In adults who have suspected cervical spine injury who meet criteria for imaging according to a clinical decision rule (e.g., Canadian C-Spine), we recommend a <b>cervical spine <b>CT</b> as the initial imaging modality. [see page 12 for C-Spine Rule] (↑↑)",
      "c": "T05"
    },
    {
      "n": "T05_1_1",
      "v": "Suspected cervical spine trauma in low-risk adults: alternative imaging",
      "t": "↪ 1.1 In low-risk patients, in settings where <b>CT</b> is not readily available, we suggest <b>XR</b> as the initial imaging modality. (↑)",
      "c": "T05"
    },
    {
      "n": "T05_2",
      "v": "Suspected cervical spine trauma: persistent concern for ligamentous or spinal cord injury",
      "t": "2. In adults with normal <b>CT</b> of the cervical spine who have persistent suspicion of significant ligamentous or spinal cord injury, we recommend<b>MRI</b>. (↑↑)",
      "c": "T05"
    },
    {
      "n": "T06",
      "v": "Suspected cervical spine trauma in children"
    },
    {
      "n": "T06_1",
      "v": "Suspected cervical spine trauma in children: High risk: initial imaging",
      "t": "1. In children with cervical spine trauma where clinical exam and/or mechanism of injury suggest high likelihood of fracture, OR if child is difficult to assess clinically (e.g., young age, distracting injuries), OR child would undergo head or chest <b>CT</b> for other injuries, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T06"
    },
    {
      "n": "T06_2",
      "v": "Suspected cervical spine trauma in children: Lower risk: initial imaging",
      "t": "2. In children with cervical spine trauma who do not meet the patient population in recommendation 1, but may require imaging (e.g., failed a clinical decision rule like PECARN), we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "T06"
    },
    {
      "n": "T06_2_1",
      "v": "Suspected cervical spine trauma in children: further investigation",
      "t": "↪ 2.1 In situations where <b>XR</b> is non-diagnostic and there is persistent clinical concern for cervical spine injury, OR if <b>XR</b> is abnormal, OR if there is clinical-radiologic discrepancy, we recommend <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "T06"
    },
    {
      "n": "T06_3",
      "v": "Suspected cervical spine trauma in children: persistent concern",
      "t": "3. In children with normal <b>CT</b> of the cervical spine who have persistent suspicion of significant ligamentous or spinal cord injury, we recommend<b>MRI</b>. (↑↑)",
      "c": "T06"
    },
    {
      "n": "T07",
      "v": "Suspected head and neck vascular injury: initial imaging",
      "t": "In patients with suspected head and neck vascular injury, we recommend <b>CT angiogram</b> as the initial imaging modality (↑↑)."
    },
    {
      "n": "T07_1_1",
      "v": "Suspected head and neck vascular injury: significant venous injury suspected",
      "t": "↪ 1.1 *In patients where there is suspicion of significant/management altering venous injury, we recommend including <b>CT venogram</b>. (↑↑)",
      "c": "T07"
    },
    {
      "n": "T08",
      "v": "Suspected thoracolumbar fracture",
      "t": "Suspected thoracolumbar fracture"
    },
    {
      "n": "T08_1",
      "v": "Suspected thoracolumbar fracture: initial imaging",
      "t": "1. In patients with suspected thoracolumbar spine fracture without neurological deficits, we recommend <b>XR</b>* as the initial imaging modality. (↑↑)",
      "c": "T08"
    },
    {
      "n": "T08_1_1",
      "v": "Suspected thoracolumbar fracture: No X-Ray needed if <b>CT</b>",
      "t": "↪ 1.1 *If <b>CT</b> of the chest, abdomen, and pelvis has been performed for other indications, given that the thoracic and lumbar spine have been included, <b>XR</b> is not recommended for initial spine assessment. (EPc)",
      "c": "T08"
    },
    {
      "n": "T08_2",
      "v": "Suspected thoracolumbar fracture with deficits: initial imaging",
      "t": "2. In patients with suspected thoracolumbar spine fracture with neurological deficits, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T08"
    },
    {
      "n": "T09",
      "v": "Acute hip and pelvic trauma",
      "t": "Acute hip and pelvic trauma"
    },
    {
      "n": "T09_1",
      "v": "Acute hip and pelvic trauma: initial imaging",
      "t": "In patients with acute hip and/or pelvic trauma, we recommend XR as the initial imaging modality (↑↑).",
      "c": "T09"
    }
    {
      "n": "T09_1_1",
      "v": "Acute hip and pelvic trauma: persistent concern",
      "t": "↪ 1.1 In situations where <b>XR</b> is negative and there is persistent clinical concern for hip and/or pelvic fracture, we recommend <b>CT</b> as the next imaging modality. (↑↑)",
      "c": "T09"
    },
    {
      "n": "T10",
      "v": "Acute shoulder trauma",
      "t": "Acute shoulder trauma"
    },
    {
      "n": "T10_1_1",
      "v": "Acute shoulder trauma: if X-Ray is negative or non-diagnostic",
      "t": "↪ 1.1 In situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> as the next imaging modality. (↑)",
      "c": "T10"
    },
    {
      "n": "T11",
      "v": "Acute elbow trauma",
      "t": "Acute elbow trauma"
    },
    {
      "n": "T11_1_1",
      "v": "Acute elbow trauma: if X-Ray is negative or non-diagnostic in skeletally mature patients",
      "t": "↪ 1.1 In skeletally mature patients, in situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> as the next imaging modality. (↑)",
      "c": "T11"
    },
    {
      "n": "T12",
      "v": "Acute hand and wrist trauma"
    },
    {
      "n": "T12_1",
      "v": "Acute hand and wrist trauma: initial imaging",
      "t": "1. In patients with acute hand and/or wrist trauma, we recommend <b>XR</b>* as the initial imaging modality. If a dislocation is identified, post-reduction <b>XR</b> should also be performed. (↑↑)",
      "c": "T12"
    },
    {
      "n": "T12_1_1",
      "v": "Acute hand and wrist trauma: further investigation",
      "t": "↪ 1.1 In skeletally mature patients, in situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> or <b>MRI</b> as the next imaging modality. (↑)",
      "c": "T12"
    },
    {
      "n": "T12_1_2",
      "v": "Acute hand and wrist trauma: scaphoid fracture suspected or CT/MRI unavailable",
      "t": "↪ 1.2 If scaphoid fracture is suspected and <b>CT</b> or<b>MR</b> is not available, we recommend immobilization and repeat <b>XR</b> in 10-14 days. (↑↑)",
      "c": "T12"
    },
    {
      "n": "T13",
      "v": "Acute knee trauma"
    },
    {
      "n": "T13_1",
      "v": "Acute knee trauma (Ottawa knee rule): initial imaging",
      "t": "1. In patients with acute knee trauma who meet the criteria in the Ottawa Knee Rule, we recommend <b>XR</b>* as the initial imaging modality. (EPc/↑↑)",
      "c": "T13"
    },
    {
      "n": "T13_1_1",
      "v": "Acute knee trauma: further investigation",
      "t": "↪ 1.1 In situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> as the next imaging modality. (↑)",
      "c": "T13"
    },
    {
      "n": "T14",
      "v": "Acute ankle trauma"
    },
    {
      "n": "T14_1",
      "v": "Acute ankle trauma (Ottawa ankle rule): initial imaging",
      "t": "1. In patients with acute ankle trauma who meet the Ottawa Ankle Rule, we recommend ankle <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "T14"
    },
    {
      "n": "T14_1_1",
      "v": "Acute ankle trauma: further investigation",
      "t": "↪ 1.1 In situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> as the next imaging modality. (↑)",
      "c": "T14"
    },
    {
      "n": "T15",
      "v": "Acute foot trauma"
    },
    {
      "n": "T15_1",
      "v": "Acute foot trauma: initial imaging",
      "t": "1. In patients with acute foot trauma in whom fracture is suspected, we recommend foot <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "T15"
    },
    {
      "n": "T15_1_1",
      "v": "Acute foot trauma: further investigation",
      "t": "↪ 1.1 In situations where <b>XR</b> is negative or non-diagnostic and there is persistent clinical concern for bony injury, we suggest <b>CT</b> as the next imaging modality. (↑)",
      "c": "T15"
    },
    {
      "n": "T16",
      "v": "Superficial soft tissue injury foreign body"
    },
    {
      "n": "T16_1",
      "v": "Superficial soft tissue injury foreign body: initial imaging",
      "t": "1. In patients with suspected superficial soft tissue foreign body, we recommend <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "T16"
    },
    {
      "n": "T16_1_1",
      "v": "Superficial soft tissue injury foreign body: further investigation",
      "t": "↪ 1.1 In situations where no foreign body is detected on <b>XR</b> and there is persistent clinical concern for foreign body, we recommend <b>US</b> as the next imaging modality. (↑↑)",
      "c": "T16"
    },
    {
      "n": "T17",
      "v": "Acute chest trauma in adults"
    },
    {
      "n": "T17_1",
      "v": "Adult minor chest trauma with low clinical suspicion: no imaging",
      "t": "1. In adults with minor chest trauma with a low suspicion of clinically significant injury*, we suggest no imaging. (↓)",
      "c": "T17"
    },
    {
      "n": "T17_2",
      "v": "Moderate to severe adult chest trauma: initial imaging",
      "t": "2. In adults with moderate to severe chest trauma, we recommend <b>XR</b> as the initial imaging modality, proceeding to <b>CT</b> if there is any clinical or radiological concern. (↑↑)",
      "c": "T17"
    },
    {
      "n": "T18",
      "v": "Acute chest trauma in children"
    },
    {
      "n": "T18_1",
      "v": "Pediatric minor chest trauma: no imaging",
      "t": "1. In children with minor chest trauma and/or where there is low suspicion of clinically significant injury, we suggest no imaging. (↓)",
      "c": "T18"
    },
    {
      "n": "T18_2",
      "v": "Pediatric moderate to severe chest trauma: initial imaging",
      "t": "2. In children with moderate to severe chest trauma, we recommend <b>XR</b> as the initial imaging modality, proceeding to <b>CT</b> if there is any clinical or radiological concern. (↑↑)",
      "c": "T18"
    },
    {
      "n": "T19",
      "v": "Acute abdominal trauma in adults"
    },
    {
      "n": "T19_1",
      "v": "Suspected internal abdominal injury: initial imaging",
      "t": "1. In adults who have sustained abdominal trauma, in whom internal injury is suspected, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T19"
    },
    {
      "n": "T19_1_1",
      "v": "Suspected internal abdominal injury: alternative imaging",
      "t": "↪ 1.1 In the specific clinical context where <b>CT</b> is not available, we suggest that <b>US</b> be used, while considering its significant limitations. (↑)",
      "c": "T19"
    },
    {
      "n": "T19_2",
      "v": "Suspected bladder injury: CT cystography",
      "t": "2. In adults with suspected bladder injury, following clinical examination and initial abdominal and pelvic <b>CT</b>, we suggest <b>CT cystography</b>. (↑)",
      "c": "T19"
    },
    {
      "n": "T20",
      "v": "Acute abdominal trauma in children"
    },
    {
      "n": "T20_1",
      "v": "Pediatric abdominal trauma: initial imaging",
      "t": "1. In children who have sustained abdominal trauma, in whom internal injury is suspected, we recommend <b>CT</b> as the initial imaging modality. (↑↑)",
      "c": "T20"
    },
    {
      "n": "T20_1_1",
      "v": "Pediatric abdominal trauma: alternative imaging",
      "t": "↪ 1.1 In the specific clinical context where <b>CT</b> in not available, we suggest that <b>US</b> be used, while considering its significant limitations. (↑)",
      "c": "T20"
    },
    {
      "n": "T20_2",
      "v": "Pediatric bladder injury: CT cystography",
      "t": "2. In children with suspected bladder injury, following clinical examination and initial abdominal and pelvic <b>CT</b>, we suggest <b>CT cystography</b>. (↑)",
      "c": "T20"
    },
    {
      "n": "T21",
      "v": "Non-accidental trauma"
    },
    {
      "n": "T21_1",
      "v": "Suspected non-accidental trauma in children: initial imaging",
      "t": "1. In children with suspected non-accidental trauma, we recommend skeletal survey <b>XR</b> as the initial imaging modality. (↑↑)",
      "c": "T21"
    },
    {
      "n": "T21_2",
      "v": "Suspected non-accidental head trauma in young children",
      "t": "2. If there is suspicion of non-accidental head trauma, especially in very young children, we suggest <b>CT</b> head. For older children, please refer to T02. Acute head trauma in children. (↑)",
      "c": "T21"
    },
    {
      "n": "B01",
      "v": "Average risk screening for breast cancer"
    },
    {
      "n": "B01A",
      "v": "Screening females for breast cancer at average risk",
      "c": "B01"
    },
    {
      "n": "B01A_1",
      "v": "Mammography/DBT screening for females under 40",
      "t": "1. In females younger than 40 years old, at average risk of breast cancer, we recommend against routine <b>mammography</b> screening. (↓↓)",
      "c": "B01A"
    },
    {
      "n": "B01A_2",
      "v": "Mammography/DBT screening for females 40-49",
      "t": "2. In females 40 to 49 years of age, at average risk of breast cancer, we suggest annual <b>mammography/DBT</b> screening. (↑)",
      "c": "B01A"
    },
    {
      "n": "B01A_3",
      "v": "Mammography/DBT screening every 1-2 years for females 50 and older",
      "t": "3. In females 50 years of age and older, at average risk of breast cancer, we recommend <b>mammography/DBT</b> screening every one to two years. (↑↑)",
      "c": "B01A"
    },
    {
      "n": "B01A_4",
      "v": "Breast cancer screening with extremely dense breast tissue",
      "t": "4. In females undergoing screening with mammographically confirmed extremely dense breast tissue (i.e., ACR category D), we suggest supplementary imaging. (↑)",
      "c": "B01A"
    },
    {
      "n": "B01A_4_1",
      "v": "Breast cancer screening for females with ACR category C dense breast tissue",
      "t": "↪ 4.1 In females with mammographically confirmed ACR category C dense breast tissue, we suggest supplementary imaging, depending on capacity constraints. (↑)",
      "c": "B01A"
    },
    {
      "n": "B01B",
      "v": "Screening trans people for breast cancer at average risk",
      "c": "B01"
    },
    {
      "n": "B01B_1",
      "v": "Transmasculine under 40 or transfeminine with <5 years hormone use",
      "t": "1. In transmasculine people under 40 years of age (with or without bilateral mastectomies) and in transfeminine individuals with no or < 5 years of hormone use, at average risk of breast cancer, we recommend against routine <b>mammography/DBT</b> screening. (↓↓)",
      "c": "B01B"
    },
    {
      "n": "B01B_2",
      "v": "Transmasculine 40-49 without mastectomy",
      "t": "2. In transmasculine people at average risk of breast cancer, aged 40 to 49 years of age, who have not undergone bilateral mastectomies, we suggest annual <b>mammography/DBT</b> screening. (↑)",
      "c": "B01B"
    },
    {
      "n": "B01B_3",
      "v": "Transmasculine 50+ without mastectomy",
      "t": "3. In transmasculine people at average risk of breast cancer, aged 50 years and older, who have not undergone bilateral mastectomies, we recommend <b>mammography/DBT</b> screening every one to two years. (↑↑)",
      "c": "B01B"
    },
    {
      "n": "B01B_4",
      "v": "Transfeminine 40-49 with ≥5 years hormone use",
      "t": "4. In transfeminine people at average risk of breast cancer with or without breast implants, aged 40 to 49 years of age, with past or current hormone use for ≥ 5 years, we suggest annual <b>mammography/DBT</b> screening. (↑)",
      "c": "B01B"
    },
    {
      "n": "B01B_5",
      "v": "Transfeminine 50+ with ≥5 years hormone use",
      "t": "5. In transfeminine people at average risk of breast cancer with or without breast implants, aged 50 years and older, with past or current hormone use for ≥ 5 years, we suggest <b>mammography/DBT</b> screening every one to two years. (↑)",
      "c": "B01B"
    },
    {
      "n": "B02",
      "v": "High-risk screening"
    },
    {
      "n": "B02A",
      "v": "Screening females at increased risk",
      "c": "B02"
    },
    {
      "n": "B02A_1",
      "v": "Breast cancer screening, high-risk due to prior chest wall irradiation",
      "t": "1. In females at high risk of breast cancer due to prior chest wall irradiation between the ages of 10 to 30 years, we recommend annual <b>mammography/DBT</b> and <b>MRI</b> screening starting 8 years after chest irradiation, but not before 25 years of age. (↑↑)",
      "c": "B02A"
    },
    {
      "n": "B02A_1_1",
      "v": "Breast cancer screening, high-risk: alternative imaging",
      "t": "↪ 1.1 If <b>MRI</b> is not tolerated, contraindicated, or unavailable, we suggest <b>US</b> as an alternative imaging technique. (↑)",
      "c": "B02A"
    },
    {
      "n": "B02A_2",
      "v": "Breast cancer screening, BRCA mutation carriers",
      "t": "2. In females with BRCA gene mutations, we recommend annual <b>mammography/DBT</b> and <b>MRI</b> screening, starting between the ages of 25 and 30 years. (↑↑)",
      "c": "B02A"
    },
    {
      "n": "B02A_2_1",
      "v": "Breast cancer screening, BRCA mutation carriers: alternative imaging",
      "t": "↪ 2.1 If <b>MRI</b> is not tolerated, contraindicated, or unavailable, we suggest <b>US</b> as an alternative imaging technique. (↑)",
      "c": "B02A"
    },
    {
      "n": "B02A_3",
      "v": "Breast cancer screening, other high-risk gene mutations",
      "t": "3. The role of screening in females with other high-risk gene mutations is an evolving science and further research is required to guide recommendations in this field. Any decision for screening should be made through shared decision making between the physician and the patient. (EPc)",
      "c": "B02A"
    },
    {
      "n": "B02A_4",
      "v": "Breast cancer screening, ≥20% lifetime risk",
      "t": "4. In females with lifetime risk of ≥20% (based on risk assessment tool), we suggest annual <b>mammography/DBT</b> and supplementary screening, preferably with <b>MRI</b>, starting between the ages of 25 and 30 years. (↑)",
      "c": "B02A"
    },
    {
      "n": "B02B",
      "v": "Breast cancer screening, trans people at increased risk",
      "c": "B02"
    },
    {
      "n": "B02B_1",
      "v": "Breast cancer screening, transfeminine ≥30 with ≥5 years hormone use",
      "t": "1. In transfeminine people at high risk for breast cancer꙳, aged 30 years and older, with past or current hormone use ≥ 5 years, guideline recommendations are identical to those presented in B02A.",
      "c": "B02B"
    },
    {
      "n": "B02B_2",
      "v": "Breast cancer screening, transmasculine ≥30 without mastectomy",
      "t": "2. In transmasculine people at high risk for breast cancer꙳, aged 30 years and older, who have not undergone bilateral mastectomies, guideline recommendations are identical to those presented in B02A.",
      "c": "B02B"
    },
    {
      "n": "B02C",
      "v": "Breast cancer screening, pregnant/lactating persons at increased risk",
      "c": "B02"
    },
    {
      "n": "B02C_1",
      "v": "Breast cancer screening, pregnant high-risk persons",
      "t": "1. In pregnant people at high risk of breast cancer who choose to continue screening, we suggest <b>mammography/DBT</b>꙳ screening and supplemental screening with <b>US</b>꙳꙳. (↑)",
      "c": "B02C"
    },
    {
      "n": "B02C_2",
      "v": "Breast cancer screening, lactating high-risk persons",
      "t": "2. In lactating people at high risk of breast cancer who choose to continue screening, we suggest that annual <b>mammography</b>/digital breast tomosynthesis and <b>MRI</b> screening resume after one year. (↑)",
      "c": "B02C"
    },
    {
      "n": "B03",
      "v": "Symptomatic patients"
    },
    {
      "n": "B03A",
      "v": "Palpable mass",
      "c": "B03"
    },
    {
      "n": "B03A_1",
      "v": "Palpable breast mass, females under 30",
      "t": "1. In females under 30 years of age with a palpable breast mass, we recommend targeted <b>US</b> of the area of clinical concern as the initial imaging technique. (↑↑)",
      "c": "B03A"
    },
    {
      "n": "B03A_1_1",
      "v": "Palpable breast mass, females under 30: further investigation",
      "t": "↪ 1.1 If <b>US</b> findings are negative, we recommend that any decision for further work-up should be based on radiologist discretion and/or clinical grounds. (EPc)",
      "c": "B03A"
    },
    {
      "n": "B03A_2",
      "v": "Palpable breast mass, females 30 years and older",
      "t": "2. In females 30 years of age and older with a palpable breast mass, we recommend <b>mammography/DBT</b> and targeted <b>US</b> of the area of clinical concern as the initial imaging techniques. (↑↑)",
      "c": "B03A"
    },
    {
      "n": "B03A_3",
      "v": "Palpable breast mass, further investigation",
      "t": "3. In females of any age with a palpable breast mass that is clinically concerning for malignancy, and <b>mammography</b> and <b>US</b> are negative, we recommend that any decision for further intervention (e.g., palpation-guided biopsy, <b>MRI</b>) should be based on clinical grounds. (EPc)",
      "c": "B03A"
    },
    {
      "n": "B03B",
      "v": "Suspicious nipple discharge",
      "c": "B03"
    },
    {
      "n": "B03B_1",
      "v": "Physiological nipple discharge",
      "t": "1. In females, at any age, with physiological nipple discharge, we recommend against imaging. (↓↓)",
      "c": "B03B"
    },
    {
      "n": "B03B_2",
      "v": "Non-physiological nipple discharge, females under 30",
      "t": "2. In females under 30 years of age with non-physiological nipple discharge, we recommend targeted <b>US</b> of the retroareolar region as the initial imaging technique. (↑↑)",
      "c": "B03B"
    },
    {
      "n": "B03B_3",
      "v": "Non-physiological nipple discharge in females 30+: initial imaging",
      "t": "3. In females 30 years of age and older with non-physiological nipple discharge, we recommend <b>mammography/DBT</b> and targeted <b>US</b> of the retroareolar region as the initial imaging techniques. (↑↑)",
      "c": "B03B"
    },
    {
      "n": "B03B_3_1",
      "v": "Non-physiological nipple discharge in females 30+: further investigation",
      "t": "↪ 3.1 If the <b>mammography</b> and <b>US</b> are negative or inconclusive, we recommend <b>MRI</b> or ductography as the next imaging technique. (↑↑)",
      "c": "B03B"
    },
    {
      "n": "B03B_3_2",
      "v": "Non-physiological nipple discharge in females 30+: all imaging negative",
      "t": "↪ 3.2 If all imaging is negative, we recommend that any decision for further work-up be based on clinical grounds, with consideration for surgical consult. (EPc)",
      "c": "B03B"
    },
    {
      "n": "B03C",
      "v": "Suspected Paget's disease of the breast/nipple",
      "c": "B03"
    },
    {
      "n": "B03C_1",
      "v": "Suspected Paget's disease: initial imaging",
      "t": "1. In females with clinical suspicion of Paget’s disease, we recommend <b>mammography/DBT</b> +/- <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B03C"
    },
    {
      "n": "B03C_1_1",
      "v": "Suspected Paget's disease: further investigation",
      "t": "↪ 1.1 If <b>mammography</b> +/- <b>US</b> are negative but clinical findings remain suspicious for Paget’s disease, we recommend that any decision for further intervention (e.g., punch biopsy, <b>MRI</b>) should be based on clinical grounds. (EPc)",
      "c": "B03C"
    },
    {
      "n": "B03D",
      "v": "Suspected inflammatory breast cancer",
      "c": "B03"
    },
    {
      "n": "B03D_1",
      "v": "Suspected inflammatory breast cancer: initial imaging",
      "t": "1. In females with clinical suspicion of inflammatory breast cancer꙳, we recommend <b>mammography/DBT</b> and <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B03D"
    },
    {
      "n": "B03D_1_1",
      "v": "Suspected inflammatory breast cancer: further investigation",
      "t": "↪ 1.1 If <b>mammography</b> and <b>US</b> are negative but clinical findings remain suspicious for inflammatory breast cancer, we recommend that any decision for further intervention (e.g., punch biopsy, <b>MRI</b>) should be based on clinical grounds. (EPc)",
      "c": "B03D"
    },
    {
      "n": "B03E",
      "v": "Suspected axillary lymphadenopathy",
      "c": "B03"
    },
    {
      "n": "B03E_1",
      "v": "Palpable axillary concern, females under 30",
      "t": "1. In patients under 30 years of age with a palpable area of concern in the axilla, we suggest axillary <b>US</b> as the initial imaging technique. (EPc)",
      "c": "B03E"
    },
    {
      "n": "B03E_2",
      "v": "Palpable axillary concern, females 30 years and older",
      "t": "2. In patients 30 years of age and older with a palpable area of concern in the axilla, we recommend axillary <b>US</b> ± diagnostic <b>mammography/DBT</b> as the initial imaging techniques. (↑↑)",
      "c": "B03E"
    },
    {
      "n": "B03E_2_1",
      "v": "Palpable axillary concern, females 30 years and older: further investigation",
      "t": "↪ 2.1 In patients with bilateral axillary lymphadenopathy on an otherwise normal mammogram AND systemic disease that is known to account for the lymphadenopathy, we recommend against further imaging. (↓↓)",
      "c": "B03E"
    },
    {
      "n": "B03F",
      "v": "Pregnant/lactation symptomatic patients",
      "c": "B03"
    },
    {
      "n": "B03F_1",
      "v": "Pregnant/lactation symptomatic patients: initial imaging",
      "t": "1. In symptomatic pregnant and lactating patients, we recommend targeted <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B03F"
    },
    {
      "n": "B03F_1_1",
      "v": "Pregnant/lactation symptomatic patients, indeterminate or suspicious: further investigation",
      "t": "↪ 1.1 In patients with <b>US</b> findings that are indeterminate or suspicious, we recommend <b>mammography/DBT</b> as the next imaging technique. (↑↑)",
      "c": "B03F"
    },
    {
      "n": "B03F_1_2",
      "v": "Pregnant/lactation symptomatic patients, concerning for malignancy: further investigation",
      "t": "↪ 1.2 In patients with clinical findings that are concerning for malignancy, and <b>US</b> and <b>mammography</b> are negative, that any decision for further intervention (e.g., palpation-guided biopsy) should be based on clinical grounds. (EPc)",
      "c": "B03F"
    },
    {
      "n": "B03G",
      "v": "Male symptomatic patients",
      "c": "B03"
    },
    {
      "n": "B03G_1",
      "v": "Gynecomastia or pseudogynecomastia in males",
      "t": "1. In males, of any age, with symptoms and physical examination consistent with gynecomastia or pseudogynecomastia, we recommend against imaging. (↓↓)",
      "c": "B03G"
    },
    {
      "n": "B03G_2",
      "v": "Breast physical exam findings: Males under 25 with suspicious findings: initial imaging",
      "t": "2. In males under the age of 25 presenting with suspicious physical examination findings꙳, we recommend targeted <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B03G"
    },
    {
      "n": "B03G_3",
      "v": "Breast physical exam findings: Males over 25 with suspicious findings: initial imaging",
      "t": "3. In males 25 years of age and older, with suspicious physical examination findings꙳, we recommend diagnostic <b>mammography/DBT</b> or <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B03G"
    },
    {
      "n": "B03H",
      "v": "Pediatric/adolescent symptomatic patients",
      "c": "B03"
    },
    {
      "n": "B03H_1",
      "v": "Palpable breast concern, pediatric/adolescent patients: initial imaging",
      "t": "1. In paediatric and adolescent patients presenting with a palpable area of concern, we suggest targeted <b>US</b> as the initial imaging technique. (EPc)",
      "c": "B03H"
    },
    {
      "n": "B03H_2",
      "v": "Palpable breast concern, pediatric/adolescent patients: no mammography",
      "t": "2. In paediatric and adolescent patients presenting with a palpable area of concern, we recommend against <b>mammography</b>. (EPc)",
      "c": "B03H"
    },
    {
      "n": "B04",
      "v": "Previous diagnosis of a high-risk breast lesion"
    },
    {
      "n": "B04_1",
      "v": "Previous diagnosis of a high-risk breast lesion: screening",
      "t": "1. In females with a previous diagnosis of a high-risk lesion꙳, we recommend annual <b>mammography/DBT</b> screening beginning at diagnosis, but not earlier than 30 years of age. (↑↑)",
      "c": "B04"
    },
    {
      "n": "B04_1_1",
      "v": "Previous diagnosis of a high-risk breast lesion, extremely dense breasts: screening",
      "t": "↪ 1.1 In females with extremely dense breast tissue (i.e., ACR category D), we suggest annual <b>MRI</b> as an adjunct. (↑)",
      "c": "B04"
    },
    {
      "n": "B04_1_2",
      "v": "Previous diagnosis of a high-risk breast lesion, MRI unavailable: screening",
      "t": "↪ 1.2 In females where <b>MRI</b> is not tolerated, contraindicated, or unavailable, we suggest screening <b>US</b> as a substitute. (↑)",
      "c": "B04"
    },
    {
      "n": "B05",
      "v": "Assessment of breast implants"
    },
    {
      "n": "B05_1",
      "v": "Breast implant evaluation screening, asymptomatic",
      "t": "1. In asymptomatic people, with breast implants of any type, we recommend against imaging for implant evaluation. (↓↓)",
      "c": "B05"
    },
    {
      "n": "B05_2",
      "v": "Breast implant, clinically definitive saline implant rupture",
      "t": "2. In people with saline breast implants and clinically definitive rupture, we recommend against imaging. (↓↓)",
      "c": "B05"
    },
    {
      "n": "B05_3",
      "v": "Suspected breast implant complications in under 30s: initial imaging",
      "t": "3. In people under 30 years of age with suspected breast implant complications, we recommend <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B05"
    },
    {
      "n": "B05_4",
      "v": "Suspected implant complications, age 30+: initial imaging",
      "t": "4. In people 30 years and older with suspected breast implant complications, we recommend <b>mammography/DBT</b> and <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B05"
    },
    {
      "n": "B05_5",
      "v": "Suspected silicone implant rupture or implant-associated lymphoma",
      "t": "5. In people with suspected rupture of silicone breast implant or implant associated lymphoma and equivocal <b>mammography</b>/US findings, we recommend <b>MRI</b> for optimal assessment. (↑↑)",
      "c": "B05"
    },
    {
      "n": "B06",
      "v": "Breast pain assessment"
    },
    {
      "n": "B06A",
      "v": "Cyclic or non-cyclic diffuse breast pain",
      "c": "B06"
    },
    {
      "n": "B06A_1",
      "v": "Cyclical, intermittent, or non-cyclic diffuse breast pain",
      "t": "1. In patients with cyclical breast pain, intermittent breast pain, or non-cyclic diffuse breast pain, we recommend against imaging, beyond usual screening recommendations. (↓↓)",
      "c": "B06A"
    },
    {
      "n": "B06B",
      "v": "Non-cyclic focal breast pain",
      "c": "B06"
    },
    {
      "n": "B06B_1",
      "v": "Focal, non-cyclical persistent breast pain in patients under 30: initial imaging",
      "t": "1. In patients under 30 years of age with focal, non-cyclical persistent breast pain, we suggest targeted <b>US</b> as the initial imaging technique. (↑)",
      "c": "B06B"
    },
    {
      "n": "B06B_2",
      "v": "Non-cyclical persistent breast pain in patients age 30+: initial imaging",
      "t": "2. In patients 30 years of age and older, with focal, non-cyclical persistent breast pain, we recommend bilateral <b>mammography/DBT</b> and targeted <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B06B"
    },
    {
      "n": "B07",
      "v": "Mastitis/infection and abscess assessment"
    },
    {
      "n": "B07_1",
      "v": "Mastitis/infection and abscess assessment: initial imaging",
      "t": "1. In patients with clinical signs and symptoms of mastitis and suspected breast abscess, we recommend targeted <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B07"
    },
    {
      "n": "B07_2",
      "v": "Mastitis without clinical improvement: initial imaging",
      "t": "2. In patients with no clinical improvement in suspected mastitis following antibiotics, we suggest diagnostic <b>mammography/DBT</b> and <b>US</b> as the initial imaging techniques. (EPc)",
      "c": "B07"
    },
    {
      "n": "B08",
      "v": "Patients with a history of breast cancer"
    },
    {
      "n": "B08_1",
      "v": "Asymptomatic patients with history of breast cancer: surveillance",
      "t": "1. In asymptomatic patients, with a personal history of breast cancer, we recommend annual surveillance <b>mammography/DBT</b>. (↑↑)",
      "c": "B08"
    },
    {
      "n": "B08_1_1",
      "v": "History of breast cancer with extremely dense breasts: surveillance",
      "t": "↪ 1.1 In patients with history of breast cancer and extremely dense breast tissue (i.e., ACR category D), we suggest supplemental annual surveillance with <b>US</b> or <b>MRI</b>. (↑)",
      "c": "B08"
    },
    {
      "n": "B08_2",
      "v": "History of breast cancer: contralateral surveillance",
      "t": "2. In patients with a history of breast cancer, we recommend contralateral annual surveillance <b>mammography/DBT</b>. (↑↑)",
      "c": "B08"
    },
    {
      "n": "B08_2_1",
      "v": "History of breast cancer and extremely dense breasts (ACR category D): supplemental surveillance",
      "t": "↪ 2.1 In patients with history of breast cancer and extremely dense breast tissue (i.e., ACR category D), we suggest supplemental annual surveillance with <b>US</b> or <b>MRI</b>. (↑)",
      "c": "B08"
    },
    {
      "n": "B08_3",
      "v": "History of breast cancer without breast reconstruction: surveillance",
      "t": "3. In patients with therapeutic mastectomy (bilateral or unilateral) without breast reconstruction, we suggest no imaging for breast cancer surveillance on the side(s) of mastectomy. (↓)",
      "c": "B08"
    },
    {
      "n": "B08_4",
      "v": "History of breast cancer without breast reconstruction with palpable concern: initial imaging",
      "t": "4. In patients with therapeutic mastectomy without reconstruction presenting with a palpable area of concern, we recommend targeted <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B08"
    },
    {
      "n": "B08_5",
      "v": "History of breast cancer, mastectomy and reconstruction: surveillance",
      "t": "5. In patients with therapeutic mastectomy and reconstruction (bilateral or unilateral), we suggest no imaging for breast cancer surveillance on the reconstructed side(s). (↓)",
      "c": "B08"
    },
    {
      "n": "B08_6",
      "v": "History of breast cancer with mastectomy and reconstruction with palpable concern: initial imaging",
      "t": "6. In patients with therapeutic mastectomy and reconstruction presenting with a palpable area of concern, we recommend <b>mammography/DBT</b> and targeted <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B08"
    },
    {
      "n": "B09",
      "v": "Patients following risk-reduction mastectomy (with or without autologous or implant-based reconstruction)"
    },
    {
      "n": "B09_1",
      "v": "Reconstructed side(s) after risk-reduction mastectomy for breast cancer: screening",
      "t": "1. In patients with risk-reduction mastectomy and reconstruction (bilateral or unilateral), we suggest no imaging for breast cancer screening on the reconstructed side(s). (↓)",
      "c": "B09"
    },
    {
      "n": "B09_2",
      "v": "Palpable concern after risk-reduction mastectomy with reconstruction: initial imaging",
      "t": "2. In patients with risk-reduction mastectomy and reconstruction presenting with a palpable area of concern, we recommend <b>mammography/DBT</b> and targeted <b>US</b> as the initial imaging techniques. (↑↑)",
      "c": "B09"
    },
    {
      "n": "B09_3",
      "v": "After risk-reduction mastectomy without reconstruction: screening",
      "t": "3. In patients with risk-reduction mastectomy without reconstruction, we suggest no imaging for breast cancer screening. (↓)",
      "c": "B09"
    },
    {
      "n": "B09_4",
      "v": "Palpable concern after risk-reduction mastectomy without reconstruction: initial imaging",
      "t": "4. In patients with risk-reduction mastectomy without reconstruction presenting with a palpable area of concern, we recommend targeted <b>US</b> as the initial imaging technique. (↑↑)",
      "c": "B09"
    }
  ]
}
